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LITERATURE REVIEW 
As shown by history, ignorance of a compound's effects on the fetus 
or extrapolation of adult responses to the fetus can prove disastrous as 
illustrated by the thalidomide tragedy (Mellin and Katzenstein, 1962). 
Presently, sudden infant death syndrome (Beckwith, 1975) is drawing much 
attention in hopes of solving this very elusive and fatal syndrome. 
Before answers to problems such as sudden infant death syndrome c.an be 
solved, fundamental knowledge about the function of the fetal cardiovas-
cular system must be obtained. 
At present, primarily sheep are used for conducting in vivo experi-
ments in fetal physiology and pharmacology. Fetal lambs are desirable 
because of their advanced maturity and size near the end of gestation. 
However the ovine breeding cycle is such that experiments can usually 
only be conducted for a few months of the year and pregnant ewes are 
expensive. Studies using sheep have indicated a difference in the mag-
nitude of responsiveness to vasopressor agents between the adult and 
fetus (Dawes et al., 1956; Assali et al., 1977). 
The guinea pig, like the lamb, is quite mature at birth. However 
unlike the lambs, guinea pigs can be bred throughout the year and give 
birth to multiple young. The guinea pig placenta is hemo-endothelial 
which is very similar to the hemochorial type found in primates. Sheep, 
unlike primates and rodents, have a syndesmochorial placenta. Another 
advantage of the guinea pig is that they are a relatively inexpensive 
laboratory animal. Dornhorst and Young (1952) found a decreased sensi-
tivity to norepinephrine in the fetal guinea pig when compared to the 
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mother, but the cause for this difference has not been extensively 
investigated. 
The study of fetal pharmacodynamics or physiology presents many 
unusual problems. The fetal cardiovascular system may have some or 
possibly all of the homeostatic mechanisms of an adult, depending on 
the gestational age and species under investigation. However, the fetus 
is not interacting with the same environment as the adult, and some of 
the vital organs present in the adult are not yet functional in the fetus. 
Yet, certain systems such as the umbilical-placental circulation are 
present in the fetus but not in the adult. The umbilical-placental cir-
culation allows for the interaction of the fetus with the adult. The 
fetal umbilical-placental unit along with nonuniform maturation of vari-
ous fetal organs and physiological systems brings about many hemodynamic 
responses in the fetus which are not comparable in the adult. 
Vasopressin when given to.pregnant cats caused a decrease in fetal 
arterial blood pressure and initiated uterine contractions. The uterine 
contractions during the period of increased maternal arterial blood 
pressure resulted in a transient increase in fetal blood pressure which 
was followed by a decrease in fetal blood pressure (Clark, 1932). 
Clamping the umbilical cord of rabbits before day eleven of gesta-
tion caused a decrease in fetal heart rate which was not altered by 
decapitation. At day twenty, clamping the umbilical cord resulted in a 
~ 
triphasic hea~t rate response; a decrease followed by an increase which 
was followed by a decrease in fetal heart rate. Up to day thirty-six, 
a gradual change in the triphasic response occurred. The transient 
increase in fetal heart rate disappeared leaving only the decrease in 
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fetal heart rate after clamping the umbilical cord (Bauer, 1938). These 
early studies indicated that fetal responses to stimuli differed from 
those of an adult. It was proposed that changing neural tone of the 
fetus was the reason for the unusual responses. 
Over the years, the investigative techniques for studying fetal 
cardiovascular responses have been refined. Experimentation on the fetal 
cardiovascular system can be broken down into two broad classes according 
to the techniques used. The first and oldest class is that of acute 
preparations in which the.fetus is partially or totally removed from the 
uterus, leaving the umbilical circulation intact. The required manipula-
tions of the fetus are performed and the parameters of interest measured. 
These experiments last only a few hours, after which the animal is termi-
nated. The second class of experiments are of a chronic nature. For 
this type, the necessary fetal manipulations are made under surgical 
anesthesia, and the fetus is placed back in the uterus. The pregnant 
animal is sutured and allowed to recover. The fetal cannulas are exposed 
for monitoring in utero fetal cardiovascular parameters (Assali et al., 
1974; Nuwayhid et al., 1975). 
There is disagreement over which of the above mentioned techniques 
is better. Investigators have shown that during complete exteriorization 
there is a decrease in umbilical blood flow while fetal blood gases remain 
unchanged (Heyraann and Rudolph, 1967). Others contend that, in an acute 
experiment although maternal cardiovascular parameters may not be the 
same as that of an unanesthetized adult, this does not invalidate acute 
preparations. It has also been shown that there is no significant differ-
ence between the fetal cardiovascular parameters in acute and chronic 
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experime~ts (Assali et al., 1974). A factor to be considered when evalu-
ating chronic versus acute fetal experiments is that with chronic experi-
ments invasive techniques are still being used and the fetal cardiovascu-
lar system does riot return to a basal level until several days post-
operative (Kirkpatrick et al., 1976). Another disadvantage of chronic 
preparations is that the number of failures is large (Assali et al., 
1974). 
If the decision is made to perform acute experiments then the effects 
of the anesthetic being used must be considered. Deep pentobarbital or 
halothane anesthesia abolishes all cardiovascular responses'to afferent 
vagal stimulation (Assali et al., 1974). The use of these anesthetics 
would not be advisable when studying the fetal cardiovascular system. 
Finally when considering the results of fetal experiments, one must keep 
in mind the physiological changes that occur to the adult animal during 
pregnancy (Assali et al., 1974). 
Anatomy of the Fetal Cardiovascular System 
In order to properly study the effects of drugs on the fetal cardio-
vascular system, it is necessary to have an understanding of fetal anatomy 
and physiology. There are entire books on each of these areas. In this 
review, I will limit myself to the factors directly related to my project. 
Four gross anatomical features of the fetal cardiovascular system 
need to be considered. The first and most obvious is the presence of 
the umbilical-placental circulation, This is a low resistance circuit 
in parallel with the fetal systemic circulation. It· provides for the 
fetus, proper gas exchange, waste removal, and a supply of nutrients. 
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The umbilical-placental circulation receives a major portion of the fetal 
cardiac output and, therefore, may greatly influence the fetal response 
to vasoactive compounds. Reliable dose response curves to norepinephrine 
could not be obtained from perfused guinea pig placentas (Panigel, 1962). 
A second anatomical difference in the fetal cardiovascular system from 
that of the adult is the ductus arteriosus. It allows oxygenated blood 
returning from the placenta to be shunted from the pulmonary artery into 
the ascending aorta, thus bypassing the nonfunctional fetal lungs. A 
third variation, the foramen ovale, allows blood to be moved from the 
right atria directly to the left atria, again bypassing the lungs. The 
fourth major anatomical difference is the ductus venosus. It is another 
low resistance shunt allowing the majority of oxygenated blood returning 
from the placenta to pass directly through the liver thereby avoiding the 
hepatic sinusoidal system. Therefore the fetal cardiovascular system will 
be exposed to a greater amount of any chemical administered because it 
is not exposed to catabolism by the hepatic microsomal system (Mirkin and 
Singh, 1972) or the lungs (Said, 1973). Located along the ductus venosus 
is a sphincter which serves to prevent overload of the heart and to main-
tain placental pressure thereby preventing collapse of the fetal villi 
(Bonica, 1967). 
In addition to gross anatomical differences, one must be aware of 
the histological differences. Rudolph and Heymann (1968) stated in a 
review article that the pulmonary blood vessels contain small amounts of 
smooth muscle during the first half of gestation, after which lumen size 
increases with wall thickness due to smooth muscle cell growth. This 
cell growth may result from increased blood pressure which has been shown 
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to stimulate vascular smooth muscle development (Levin et al., 1978). 
Regarding myocardial differences, the number of myofibrils is less in the 
fetus than in the adult, and the fetal myocardium has a greater percentage 
of noncontractile mass than does the adult (Friedman, 1973, as cited by 
Rudolph and Heymann, 1974). Work on the human heart has shown that the 
sino-atrial node contains a large number of pacemaker cells which decrease 
in number with increasing gestational age. The atrioventricular node and 
the bundle of His are poorly defined, and the action potentials of the 
fetal myocardium show widespread pacemaker activity which, in adults, is 
found only in the sino-atrial and Purkinje fibers (Coltart, Spilker, and 
Meldrum, 1971). 
Neural innervation of the fetal myocardium from a developmental 
standpoint is species specific. The fetal guinea pig heart has complete 
synipathetic and parasympathetic innervation at day thirty of a sixty-five 
day gestational period (Hoar and Hall, 1970; Pappano, 1977). It should 
be noted that the physical presence of neurons does not mean that they 
are functional. This is illustrated by the fact that, although para-
sympathetic innervation of the heart precedes sympathetic, the sympathetic 
tone exceeds parasympathetic tone throughout gestation (Nuwayhid et al., 
1975; Rudolph and Heymann, 1974; Assali et al., 1977). 
A possible alternative to neural control has been proposed for the 
fetal myocardium and large arteries of the neonatal rabbit, which contain 
small intensely fluorescent cells (Papka, 1975). These cells contain 
dense core vesicles and are acetylcholinesterase positive. Some neural 
enlargements occur near these small intensely fluorescent cells. These 
enlargements ?re also acetylcholinesterase positive. It has been suggested 
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that these small intensely fluorescent cells may release catecholamines 
or even acetylcholine prior to neural innervation, thereby acting as a 
local regulating mechanism. Regarding the systemic circulation, it 
appears that its innervation lags behind that of the myocardium (Wyse 
et al., 1976; Harris and Van' Petten, 1978) with development continuing 
postpartum. 
Fetal Cardiovascular Parameters and Function 
Having presented the major anatomical differences between the fetus 
and adult, it is necessary to discuss the functional differences. It has 
been found that as gestation progresses there is a gradual increase in 
fetal blood pressure. During the last trimester, the mean fetal blood 
pressure in lambs increased from 46 mm Hg to 67 mm Hg (Joelsson et al., 
1972; Assali et al., 1977). This value compares to an adult sheep value 
of 93 mm Hg (Biological Handbooks, Respiration and Circulation, 1971). 
Regarding the gradual rise in fetal blood pressure as gestation progresses, 
it is of interest that vagotomy in near term lambs has no effect on pul-
monary resistance whereas sympathectomy results in pulmonary vasodilation 
(Rudolph and Heymann, 1968). Perhaps the sympathetic autonomic nervous 
system exerts an increasing amount of tone on the peripheral and pulmonary 
circulations as gestation progresses. 
Just as circulatory shunts affect fetal blood pressure, blood flow 
to the various organs differs from the adult and also shows major change 
throughout gestation. In utero alterations of specific organ perfusion 
result from redistribution rather than changes in cardiac output. For 
example, as gestation progresses the percentage of cardiac output 
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distributed to the lungs gradually increases while that to the placenta 
decreases. This change may result from either an increase in placental 
resistance or a decrease in pulmonary resistance. At approximately 100 
days gestation in the lamb, the pulmonary flow suddenly increases. Sur-
face active materials appear in the lungs at this same time, and this 
sugges.ts that the increased flow results from increased metabolic needs. 
A rapid increase in gut blood flow occurs at approximately 120 days of 
gestation. This too may be the result of increased metabolic needs. 
Throughout gestation an increase in blood flow to the brain occurs. This 
increase is gradual and is most likely the result of blood vessel pro-
liferation (Rudolph and Heymann, 1970). 
The fetal blood gases vary greatly from those of an adult. Nonnal 
values for fetal sheep are Pao
2 
= 24 mm Hg, Paco
2 
= 45 mm Hg, and pHa = 
7 .330 (Dawes, 1968). These compare to maternal values of Pao
2 
= 82 nun Hg, 
Paco2 = 36 nun Hg, and pHa = 7.440. Perhaps this difference in blood gases 
and pH plays a role in the responsiveness of maternal and fetal tissues 
to stimuli. 
With basal fetal cardiovascular parameters changing throughout 
gestation, one expects the cardiovascular reactions to vary depending upon 
the stage of fetal development. Of major concern with regard to the car-
diovascular reactivity is the functional development of the autonomic 
nervous system. In premature and immature lambs, no parasympathetic tone 
is present, and the mature fetal lamb has only a small degree of para-
sympathetic tone. In all three of the above fetal age groups, however, 
the parasympathetic system was capable, if stimulated, of exerting an 
influence on the cardiovascular system (Nuwayhid et al., 1975; Assali 
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et al., 1977). 
Activation of adrenergic receptors is present in the lamb as early 
as day 60 of gestation. Whether this receptor activity is the result of 
transmitter release from nerves or small intensely fluorescent cells is 
unknown. There is some evidence to indicate that receptor activation 
increases with gestational age, as shown by changes in fetal blood pres-
sure and heart rate when alpha and beta-adrenergic blockers were adminis-
tered to the fetus (Nuwayhid et al., 1975). However, these data were 
obtained from experiments in which the fetus may not have been totally 
recovered from the trauma of the surgical procedure. In the fetal lamb, 
the release of catecholamines from the adrenal medulla in response to 
asphyxia is greater than that resulting solely from splanchnic nerve 
stimulation. As gestation. progresses, the role of splanchnic stimulation 
in the adrenal medulla response to asphyxia increases in comparison to 
the direct effect of asphyxia on the adrenal medulla. In young fetal 
lambs and other animals which ·are quite neurologically immature at birth, 
it appears that circulating catecholamines resulting from the direct 
effect of hypoxia on the adrenal medulla play a more prominent role in 
cardiovascular control than in the adult. In the fetal lamb at 125 days 
of gestation, norepinephrine is the primary catecholamine released from 
the adrenal medulla. With increasing gestational age, epinephrine becomes 
the more prominent catecholamine being released from the adrenal medulla 
(Comline and Silver, 1961). 
The baroreceptors are a primary mechanism for providing cardiovascu-
lar control in the adult. The gestational age at which baroreceptors 
provide control of the fetal cardiovascular system and the degree of 
, 
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control exerted is still disputed. Some investigators have found that 
baroreceptor activity is present at 0.55 of gestation in fetal lambs while 
others contend that baroreceptor reflexes develop from 0.68 of gestation 
on (Boddy, 1976). 
Working in conjunction with the baroreceptors are the chemoreceptors. 
The fetal responses to asphyxia and hypoxia are complex and variable.and 
will not be discussed in depth .. The chemoreceptors of the carotid body 
appear to play a minor role when compared to the aortic body chemorecep-
tors in the fetal lamb. It is felt that the latter is supplied by blood 
from the pulmonary trunk rather tha~ the aorta. This exposes the recep-
tors to a higher co
2 
concentration thus making them more sensitive to 
changes in the fetal physiological condition (Dawes, 1968). The response 
of fetal lambs to asphyxia is in part a pulmonary vasoconstriction. This 
vasoconstriction is abolished by sympathectomy and adrenalectomy in fetuses 
greater than 100 days gestational age. However, in fetuses of 90 days 
age and less, the vasoconstriction persists after sympathectomy. In the 
older age group of fetal lambs, in addition to the pulmonary vasoconstric-
tion, a hindlimb vasoconstriction takes place (Born et al., 1956; Dawes, 
1968). The vasoconstriction of these vascular beds increases placental 
blood flow by 30-50 percent while coronary and cerebral blood flow increases 
8-10 times. Thus a shifting of blood flow to the vital organs,' excluding 
the lungs, occurs during asphyxia (Dawes, 1966; Campbell et al., 1967). 
The peculiarity of the fetal cardiovascular system's reactivity is 
illustrated by the pulmonary vasculature's response to elevated intra-
cranial pressure. In neonatal goats, an increased intracranial pressure 
resulted in pulmonary hypertension. However in fetal goats, the same 
. ./ 
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magnitude o·f increased intracranial pressure elicited pulmonary vasodila-
tion (Hessler and Cassin, 1977). It was proposed that, because the pul-
monary vasculature of the fetus is already constricted, sympathetic acti-
vation in response to increased intracranial pressure could result only 
in vasodilation. However, the pulmonary response to asphyxia as described 
previously does not lend credence to this hypothesis. A slight pulmonary 
vasodilation has been noted in adults in response to elevated intracranial 
pressure but not to the extent reported in the fetus (Lloyd, 1973). 
Fetal Cardiac Function 
In the fetal heart, both the conductive system and myocardium have 
been found to be functionally different from the adult. The fetus has a 
cardiac output which is approximately two times that of an adult (Rudolph 
and Heymann, 1974). This high cardiac output provides a safety margin 
for the fetus, in light of the fact that the oxygen tension of the fetal 
blood is low compared to the adult (Dawes, 1968). It must also be remem-
' bered that fetal hemoglobin has a higher affinity for oxygen than maternal 
hemoglobin. Therefore, some propose that a greater blood flow is needed 
to provide an adequate oxygen supply to the tissues (Klophenstein and 
Rudolph, 1978). 
Cardiac output can be changed by altering either heart rate or stroke 
volume. Initially it was .thought that lamb fetal heart rate was constant 
throughout gestation (Reynolds, 1954). However with the refinement of 
techniques, more recent studies have shown that as gestation progresses 
the fetal heart rate gradually decreases. During the last trimester of 
pregnancy, the heart rate in lambs decreased from an average of 20.0 to 
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170 beats per minute (Joelsson et al., 1972; Assali et al., 1977; 
Klophenstein and Rudolph, 1978). This compares with an adult heart rate 
of 75 beats per minute (Biological Handbooks, Respiration and Circulation, 
1971). A decreasing heart rate points towards an increasing influence of 
the parasympathetic nervous system or to a decreasing sympathetic tone 
on the heart. Atropine and propranolol altered cardiovascular parameters 
to the same extent in both neonatal and adult sheep. Therefore, this 
decrease in fetal heart rate which occurs during gestation appears to be 
a result of intrinsic changes of the myocardial pacemaker and conduction 
system (Assali et al., 1977; Klophenstein and Rudolph, 1978). In vitro, 
human atria up to 20 weeks of gestational age show a decreasing basal 
rate with increasing gestational age. Atropine had no effect on resting 
rate nor did propranolol or cocaine. Stretching, which increases the 
rate of sino-atrial node firing in the' adult, had no effect on the fetal 
sino-atrial node firing rate (Walker, 1974). Therefore, the continuous 
decrease in rate prior to 20 weeks in the human fetal heart must result 
from intrinsic changes in resting membrane potential, possibly via the 
sodium pump. It has also been suggested that the decrease in spontaneity 
of the sino-atrial node may be related to increased cell cluster size of 
the sino-atrial node (DeHaan and Sachs, 1973, as cited by Walker, 1974). 
Concerning the metabolism of the fetal myocardium, Su and Friedman 
(1973) found that, under hypoxic conditions, adult sheep hearts in vitro 
ceased functioning after approximately 10 minutes while fetal hearts 
co.ntinued to beat for 1-2 hours. In contrast, with the blocking of 
glycolysis under otherwise normal conditions, the fetal heart failed 
faster than the adult heart. Similar results were obtained using adult 
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and fetal rat hearts (Shepard et al., 1969). This decreased tolerance to 
hypoxia was correlated to an increase in enzymes involved in oxidative 
phosphorylation. Others found the amount of glycolytic enzymes in neo-
natal and fetal guinea pigs to be more than that of the adult (Barrie 
and Harris, 1977). These data indicate that the fetal heart is more 
dependent upon anaerobic glycolysis than oxidative phosphorylation for 
energy. 
When comparing. the mechanical properties of fetal and maternal myo-
cardium, one finds obvious differences. The fetal and neonatal heart 
are less compliant and maintain higher resting tensions at any point 
along the length-tension curve (Friedman, 1973, cited in Rudolph and 
Heymann, 1974). Previously it was contended that Frank-Starling's Law 
of the heart was not important in the fetus and that cardiac output could 
only be increased by increasing the rate (Heymann and Rudolph, 1973). 
However, Kirkpatrick et al. (1976) have shown that myocardial fiber length 
is an important control mechanism in the fetus in utero in that the fetus 
can increase its stroke volume over a range of 2.5-8.0 mm Hg before 
failure occurs. The overall lower performance of the fetal heart could 
be the result of fewer sarcomeres or a possible disturbance of the excita-
tion contraction coupling mechanism (Friedman, 1973, cited by Rudolph and 
Heymann, 1974). Contrasting this lower fetal cardiac performance is the 
fact that pressure induced enlargements of the left ventricle during 
fetal growth did not affect the neonates' ability to respond to isopro-
terenol or to compensate for overloading. This is unlike pressure induced. 
enlargements of adult hearts which result in a compromise of cardiac 
function. These enlargements also diminished myocardial DNA of the adult 
14 
but the myocardial DNA content of the neonate was increased (Dowell and 
McManus, 1978). 
Bradycardia, whatever the cause; can be classified into two cate-
gories. The first type is of vagal origin and occurs in the fetus during 
hypoxia or grunting. Vagal mediated bradycardia is associated with 
increased vascular resistance and excitation of baroreceptors. The 
second type of bradycardia can be called terminal bradycardia and is not 
vagally mediated since the effect is not prevented by atropine. Systemic 
hypertension is not the underlying cause of this second type of brady-
cardia (Goodlin and Haesslein, 1977). The duration of the bradycardia 
is important because during fetal bradycardia the systolic time interval 
does not increase. This leads to decreased cardiac output which can be 
detrimental if prolonged. Investigations of fetal bradycardia in fetal 
guinea pigs and lambs showed that with severe hypoxia there occurred a 
sudden onset bradycardia which resulted from a Type II A-V block in the 
lamb. In the guinea pig, changes in the S-T segment of the fetal ECG 
were seen prior to bradycardia. Isoproterenol caused changes in the 
ECG similar to those resulting from hypoxia. Both isoproterenol and 
mild hypoxia related changes were prevented by propranolol (Rosen, 1976). 
Changes in the ECG which precede bradycardia indicate direct myocardial 
depression. Additional evidence supporting the idea of direct myocardial 
depression during hypoxia is the fact that the bradycardia is correlated 
with depletion of fetal liver, brain, and cardiac glycogen stores. Also, 
metabolic but not respiratory acidosis was associated with fetal ECG 
changes. 
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Fetal Cardiovascular Response to Drugs 
Throughout gestation the fetus may be exposed to a number of exogenous 
compounds, perhaps as a treatment for a maternal or fetal disorder or to 
assist in parturition. In these instances of treatment, to ensure the 
health of both mother and fetus, the following considerations must be 
made: drug action in the mother along with metabolism and elimina-
tion, placental crossing, fetal distribution, and fetal responsiveness 
(Van Petten, 1975). The inability to predict drug action on the fetal 
cardiovascular system has been demonstrated. When chlorpromazine or 
pentobarbital were administered to pregnant goats, the maximal blood con-
centration obtained by the fetus was one-half that of the mother. Chlor-
promazine caused an increase in maternal heart rate while pentobarbital, 
contrary to what one would predict, resulted in a decreased maternal 
heart rate and both of the drugs caused an increase in fetal heart rate. 
I 
Phenylbutazone also crosses the placenta causing fetal ECG changes and 
renal damage (Boulos et al., 1971). Maternally administered cardiac 
glycosides have been shown to attain fetal cardiac concentrations up to 
six times those of simultaneously measured maternal cardiac concentra-
tions when expressed on a per gram of cardiac tissue basis (Mirkin and 
Singh, 1972), Sharpe (1974) found that indomethacin given to pregnant 
rats caused a decrease in the diameter of the ductus arteriosus. Abnormal 
blood gases were measured in these resultant neonates when compared to 
control animals. 
Interpreting the hemodynamic responses of the fetus to drugs requires 
an understanding of developmental anatomy, physiology, and pharmacology. 
The explanation for the lack of parasympathetic tone to the heart as 
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mentioned previously is disputed. Acetylcholinesterases have been found 
in the chick embryo heart preceding vagal innervation, and electrical 
stimulation of these hearts causes the release of acetylcholine, thereby 
affecting cardiac automaticity (Pappano, 1977). In mouse, rat, and human 
cardiac tissue, acetylcholine also exerted a negative chronotropic effect 
before neural innervation. In the mouse atria, the effect of a given 
concentration of acetylcholine increased as gestational age increased 
(Wildenthal, 1973; Gennser and Nilsson, 1970; Robkin et al., 1976). 
Investigators (Friedman, 1972). have also found that the acetylcholine 
dose response curves for fetal lamb hearts were similar to those of 
adult hearts. Regarding the vascular response to acetylcholirte, pulmonary 
vasodilation is seen, but little effect on the systemic vasculature occurs, 
and the acetylcholine ED
50 
for a given type of blood vessel remains 
unchanged as gestation progresses (Dawes, 1966; Dawes, 1968; Rudolph and 
Heymann, 1968; Nuwayhid et al., 1975). 
As with acetylcholine, prior to innervation of the rat and human 
heart adrenergic compounds elicit a response, thereby demonstrating that 
adrenergic receptors are present and functional (Gennser and Nilsson, 
1970; Robkin et al., 1976). Electrical stimulation of isolated human 
atria prompted norepinephrine release from the autonomic ground plexus, 
and nicotine elicited positive inotropic responses when electrical stimu-
lation failed (Walker, 1975). Perhaps the neurotransmitter(s) affecting 
the heart in this latter instance originate(s) from the small intensely 
fluorescent cells, described previously in this review. 
For proper neural function, there must be an adequate supply of 
transmitter present. In human hearts from fetuses 11-23 cm in length, 
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norepinephrine synthesis occurred at the same rate as in the adult 
(Gennser and Studnitz, 1975), and within hours after birth the norepineph-
rine concentration per unit weight increased throughout the body (Roffi 
and Motelica-Heino, 1975). Perhaps this results from an increased meta-
bolic rate accompanying the increased availability of oxygen at birth. 
The tyrosine hydroxylase activity, which is of primary importance in 
norepinephrine synthesis, was less in fetal lambs than neonates (Friedman, 
1972). In conjunction with this decreased tyrosine hydroxylase activity, 
the norepinephrine stores in the heart were lower in the fetus and this 
was associated with a paucity of sympathetic innervation. This paucity 
of innervation was proposed as the cause of the increased sensitivity of 
the fetal lamb myocardium to norepinephrine when compared to the mother 
in vitro, presumably due to a lack of uptake (Friedman, 1972; Euler, 1972). 
From work on mouse atria (Wildenthal, 1973) it appears that, although the 
magnitude of chronotropic response increases from 15-16 days gestation on, 
the sensitivity to norepinephrine remained the same, i.e., the En
50 
values 
were unchanged. These .!!!. vitro studies indicate a similarity between 
maternal and fetal sensitivity to norepinephrine in these species. How-
ever, the administration of catecholamines .!!!. ~ shows that the fetus 
is less responsive than the mother with respect to blood pressure changes 
(Assali et al., 1977). Despite the decreased magnitude of the fetal 
response in in ~ experiments in which fetal weight was estimated, the 
·threshold dose for norepinephrine in the fetus and the mother was the 
same and the ED50 value did not change as gestation progressed (Nuwayhid 
et al., 1975; Priviteria et al., 1968). Some drug responses in the fetus 
are altered from those of the adult, and it does not appear to be an 
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instance of decreased fetal sensitivity. Arrhythmias and cardiac arrest 
are often seen at low doses of isoproterenol in the fetus but not the 
mother. Propranolol, a beta-adrenergic antagonist, shifted the dose 
response curves for isoproterenol in the pregnant ewe to the right by 
an equivalent degree in both the ewe and fetus. The blockade by propran-
olol in the fetus was however 2-3 times the duration of that in the ewe 
whereas the maximal propranolol concentration in the fetus was only 5 
percent of that present in the ewe (Truelove et al., 1973; Van Petten 
and Willes, 1970). Vasopressors and vasodepressors are not the only 
drugs to which the fetus exhibits an altered responsiveness in ~· 
Berman et al. (1977) found digoxin to be less potent in the fetus than in 
the adult. 
Isolated Tissue Studies 
In spite of the fact that in vitro studies have indicated similar 
sensitivities to parasympathomimetic and sympathomimetic compounds, in 
vivo experiments suggest the presence of both qualitative and quantita-
tive differences between fetal and maternal responses to vasoactive drugs. 
The cause of these differences is unresolved. Some feel that the presence 
of the low resistance umbilical-placental circulation is the cause of 
these differences (Assali et al., 1977; Dawes, 1968). However, an imma-
turity of a portion of the neuroeffector mechani~m is another possible 
explanation. One portion of the neuroeffector mechanism which can be 
examined is the receptor. When seeking to characterize receptors, one 
should use in vitro techniques since in vivo experiments present many 
variables which cannot be controlled (Furchgott, 1972; Furchgott, 1967). 
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Initially, adrenergic receptors were classified into alpha (a) and 
beta (S) subgroups (Alquist, 1948). Later the beta-adrenergic receptors 
were subclassified into beta
1
, those affecting the heart and lypolysis, 
and beta2 , those associated with vascular and bronchial relaxation (Lands, 
1967). Presently, evidence is mounting for the subclassification of 
alpha-adrenergic receptors into alpha
1 
and alpha
2 
(Wikberg, 1978). Alpha
1
-
adrenergic receptors are associated with vasoconstriction, and alpha2-
adrenergic receptors are associated with the central nervous system and 
renin release from the kidneys. With the recent realization that subunits 
of adrenergic-receptors exist, it seems possible that in the fetus the 
distinction between receptor types has not clearly developed and their 
affinity for adrenergic drugs may differ from that of the adult. 
Barret et al. (1972) demonstrated that stimulation of beta
1
-adrenergic 
receptors was effective as early as 0.4 gestational period in the fetal 
lamb while responses to alpha-adrenergic stimulation first appeared at a 
gestational age of 0.5. Others have shown that beta
1
-adrenergic receptors 
of the fetal rat heart bind norepinephrine and activate adenyl cyclase 
but no inotropic or chronotropic responses are seen (Martin et al., 1973). 
Looking at this evidence, the difference between maternal and fetal heart 
reactivity seems to lie at some point beyond receptor activation, perhaps 
an alteration in the calcium pools, an absence of enzymes associated with 
contraction, or various physical arrangements of contractile proteins in 
cardiac muscle. 
To complement the cardiac studies, work on isolated fetal·blood 
vessels has been carried out. The information regarding the mechanics 
of smooth muscle contraction is in itself limited (Dorbin and Canfield, 
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1973). It is known that the response to norepinephrine varies in rela-
tion to the strain upon the vessel prior to excitation (Dorbin, 1973). 
This is due to the fact that the passive tissue elements determine the 
length of the contractile elements, thus altering vessel reactivity. Also, 
if the collagen:elastin ratios of various vessels differ, regardless of 
the fact that the total amount of connective tissue may be the same, the 
mechanics of contraction of the vessels will differ (Cox, 1975). 
Despite the fact that much remains to be determined regarding the 
mechanics of smooth muscle contraction, vital information regarding 
receptor mechanisms can be obtained from isolated tissue studies if the 
following guidelines are adhered to. First is the acceptance of Clark's 
theory (Goodman and Gilman, 1975) that the magnitude of a drug response 
is proportional to the number of receptors occupied. Second, that the 
conditions set forth by Furchgott (1972) for conducting isolated tissue 
experiments are met. These are discussed in detail in the Methods and 
Materials section. 
Using isolated tissue techniques, the beta
2
-adrenergic receptors of 
newborn rabbits wer·e studied by measuring their ability to relax strips 
of aorta. Sodium nitrite relaxed vessels of all age groups equally 
whereas isoproterenol was less effective in animals less than 10 days of 
age than in adults (Park et al., 1976). The pA
2 
values which characterize 
the receptors were the same for neonates and adults. This information 
indicates that some site beyond the point of receptor activation is 
altered in neonatal blood vessels. This reflects the situation existing 
in fetal rat myocardillm (Martin et al., 1973) mentioned earlier in this 
literature review. In other animal studies, no difference was found in 
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the pA
2 
value for alpha-adrenergic receptors in fetal lambs nor the ED50 
of norepinephrine as gestation progressed (Wyse et al., 1976). With 
respect to the muscarinic receptors, the pD2 values for acetylcholine 
in the guinea pig intestine are the same for mother and fetus (Boreus 
and McMurphy, 1971). Information such as this indicates that the 
receptor affinity for cholinergic and adrenergic compounds is the same 
in both the adult and fetus. This does not, however, eliminate the 
possibility of an increase in the number of receptors as tissue growth 
occurs. 
Studies on the sequential development of the entire neuroeffector 
mechanism in fetal lambs were performed by Su et al. (1977). This investi-
gation revealed that enzymatic mechanisms for degradation of norepineph-
rine were present at early stages of gestation. This was followed in 
sequence by alpha-adrenergic receptor development, neuronal transmitter 
uptake, and finally neuronal release of transmitter. 
Despite the descrepancies in some of the results and the nonstandard-
ized techniques used for in~ experiments, certain points are evident: 
1) the fetal cardiovascular response to a vasoactive drug differs from 
that of the adult, and 2) this difference lies in part at some point 
beyond receptor activation. 
The preceding literature review presented some of the major anatomi-
cal and physiological differences between the fetal and adult cardiovas-
cular systems. It appears as though the overall differences in reactivity 
of the fetal and maternal cardiovascular systems are partially based on 
a difference at the cellular level. This allows one to hypothesize that 
the low resistance shunts of the fetal cardiovascular system may not be 
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the primary cause for the altered sensitivity of the fetus to drugs as 
has been proposed (Assali et al., 1977; Dawes, 1968). 
Statement of the Problem 
From the information in this literature review, it is evident that 
there is a large amount of uncertainty in the field of fetal pharmaco-
cynamics. With this is mind, the following goals were established: 
1) to develop and use the guinea pig model for studying fetal pharmaco-
dynamics since it is a low cost, readily available laboratory animal with 
a breeding cycle that permits experimentation throughout the year, 2) to 
use this model to study fetal and maternal responses to biogenic amines, 
and 3) to use isolated tissues (and appropriate techniques) from the 
mother and fetus to better define the difference in responsiveness between 
mother and fetus observed in the in vivo experiments. 
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METHODS AND MATERIALS 
Breeding 
Guinea pigs (Cavia cabaya) were obtained through Laboratory Animal 
Resources at Iowa State University where their physical condition was 
examined. Animals of ill health we.re not accepted. As this project pro-
gressed an average of two timed pregnant guinea pigs a week was necessary, 
and this necessitated setting up a breeding program. This required a 
breeding stock of approximately 15-20 females weighing at least SOOgms 
along with three mature males. To maintain an adequate number of animals 
in the colony, each week the newly bred females were replaced with non-
pregnant females. The guinea pigs were housed separately to limit the 
spread of disease. 
To obtain timed pregnancies, it was necessary to determine when the 
animal was in estrous. In guinea pigs this can be done by examining !=he 
membrane covering the vaginal opening which is easily visible when the 
animal is in dorsal recumbency. ·This membrane ruptures just prior to 
estrous and will remain open for 1-3 days (Elvidge, 1972; Manning and 
Wagner, 1976). The membrane starts reforming after ovulation has 
occurred. 
The vaginal membranes of the nonpregnant guinea pigs were checked 
daily for a period of three weeks after their arrival at the colony. 
This allowed the animal to complete one sexual cycle and the date of 
membrane disappearance was determined. With this information, one can 
predict the next ovulation date to be an average of 16 days from the 
observed breaking of the vaginal membrane. Two days prior to the predicted 
24 
ovulation date the female was placed in a cage with a male. During this 
breeding period, daily checks were made for the presence of the membrane. 
After the membrane broke, mating was indicated by the presence of a white 
vaginal mucous plug (1-2 cm in length, 0.5 cm in diameter) in the bottom 
of the cage (Manning and Wagner, 1976). In this study, the day that the 
plug appeared was designated as day one of gestation. After a successful 
breeding, the female was separated from the male and daily examination 
was no longer performed in order to minimize excitement and decrease the 
chance of abortion. The gestation period for a guinea pig averages 68 
days (Manning and Wagner, 1976), and pregnancy can be confirmed by palpa-
tion at 25 days (Elvidge, 1972; Matthews and Jackson, 1977). Females 
were utilized for in vivo experiments on day 60 ± 2 of gestation. 
When setting up a· breeding program, one must consider that some 
females may abort and some die from disease. It is therefore convenient 
to have contacts with an external supplier of timed pregnancies that can 
supply you during a period in which there are no pregnant females near 
term in the colony. If a supplier can provide pregnant guinea pigs with 
no breeding dates, palpation of the fetal head plus spreading of the 
maternal pubic symphysis can be used to estimate the last week of gesta-
tion (Manning and Wagner, 1976). 
!!l Vivo Experiments 
Anesthesia 
. 
For conducting the .!.!!. ~ experiments, two methods of anesthesia 
were used. Pentobarbital sodium (20 mg/ug) given intrathoracically with 
supplemental doses (5 mg/kg) was used in six animals. For the remaining 
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experiments, anesthesia was induced with sodium thiopental (20 mg/kg) 
given intrathoracically with additional doses (5 mg/kg) administered to 
obtain the desired depth of anesthesia. After being anesthetized, the 
pregnant female was tied in dorsal recumbency on a thermal pad adjusted 
to approximately 103° F. Anesthesia was maintained with methoxyflurane 
administered with a small animal anesthesia apparatus constructed in our 
laboratory (Luschei and Mehaffey, 1967) and delivered using compressed 
room air through a small animal face cone. The animals were allowed to 
respire on their own and adequate depth of anesthesia was determined 
using withdrawal reflexes. 
Cannulations 
A midline incision was made along the ventral aspect of the neck, 
with lidocaine used along all lines of the incision. A traecheostomy 
was performed using polyethylene #240 tubing. The anesthetic gas mixture, 
which was previously being administered through a face mask was made to 
pass over the end of the endotracheal tube while the animal breathed 
spontaneously. The maternal common carotid and external jugular blood 
vessels were cannulated for arterial blood pressure monitoring and adminis-
tration of the drugs, respectively. Heparinized 0.15 M saline (10 USP 
units/ml) was used to maintain catheter patency. .After these cannulations 
were completed, arterial blood gas values were obtained for the mother. 
If necessary, the concentration of anesthetic in the gas mixture was 
adjusted to prevent severe hypoxia. 
After locating a fetus which was in a suitable position, by palpation 
of the fetal head a transverse incision of approximately 5 cm in length 
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was made through the maternal abdominal wall and peritoneum using a 
cautery unit. A circular operating field was secured by suturing the 
skin and muscle surrounding the incision to a plastic coated oval lead 
ring which was attached to an upright ringstand (Figure 1). The lead 
ring could be adjusted to acconunodate incisions of various sizes and 
locations. 
The cautery unit was then used to make an incision in the uterus 
parallel to the major uterine blood vessels to expose the fetal head. 
The edges of the uterine incision were sutured to the maternal abdominal 
wall and the fetus gently lifted part way out to expose the ventral 
aspect of the neck. The amniotic membrane was cut from around the neck 
region leaving the head covered by the membrane. A suture was passed 
under the upper incisors of the fetus taking care not to break the amni-
otic membrane. This suture was tied to the aforementioned ringstand 
and secured the position of the fetus with .the exposed ventral aspect 
of the neck perpendicular to the horizontal operating plane. A one cm 
midline incision was made along the ventral aspect of the fetal neck 
using a cautery unit. The conunon carotid artery and external jugular 
vein were then gently separated from the surrounding tissue using micro-
surgical forceps. Suture (6-0) was passed under each blood vessel while 
gently lifting the blood vessel. This prevented rotation of the vessel 
as the suture was passed underneath. 
Cannulation was performed by gently lifting the blood vessel with 
spread forceps to occlude the blood flow. A cut was made with micro-
surgical scissors through the wall of the blood vessel segment located 
between the tips of the spread forceps. The cannula was gently inserted 
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Fig. 1. Experimental setup 
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into the blood vessel and secured using a surgeons knot. Polyethylene 
tubing #10 was used to cannulate the fetal jugular vein. The carotfd 
artery cannula was prepared from polyethylene tubing ISO which had been 
heated in boiling water, stretched, and cut to obtain a tapered beveled 
end. This facilitated the entry of the cannula into the blood vessel. 
The carotid and jugular cannulas were used to monitor blood pressure 
and administer drugs, respectively. The arterial cannula was maintained 
patent by periodically flushing with heparinized 0.15 M saline (100 USP 
units/ml). 
To minimize the volume of injection required for drug administration 
to the fetus, the apparatus in Figure 2 was constructed. The maximal 
volume required to deliver a drug to the fetus with this device was 
300 pl. 
Blood pressure and heart rate monitoring 
Blood pressure and heart rate were recorded with a Beckman R-611 
Dynograph recorder. Arterial blood pressure was monitored using a Bell 
and Howe type 4-327-0121 physiological pressure transducer connected to 
a type 9853A voltage/pulse pressure coupler of the recorder. To negate 
any damping effect that the cannulas might have had on the pressure 
waves, all blood pressures were converted to mean blood pressures accord-
ing to Riggs (1963) as, 
where Cp is mean blood pressure, Cpt
1 
is systolic blood pressure, and 
Cpt2 is diastolic blood pressure. Heart rate was determined using a 
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Figure 2 . Fetal injection apparatus 
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type 9857B cardiotachometer coupler triggered by the pulse pressure wave 
of the arterial pressure recording. 
Blood collection and analysis 
Anaerobic blood samples were collected in one ml heparinized (100 
USP units/ml) plastic syringes. Analysis of arterial oxygen partial 
pressure (Pa0
2
), arterial carbon dioxide partial pressure (Paco2), pH, 
bicarbonate ion, and base excess was performed· using a pH/Blood Gas 
Analyzer 513 (Instrumental Laboratories). 
Design 
The following drugs were administered intravenously to both mother 
and fetus on a per kg body weight basis: norepinephrine, isoproterenol, 
acetylcholine, phenylephrine, and atropine. The drugs were administered 
using physiological saline as the carrier and made up fresh for each 
experiment from frozen (1 mg base/ml) stock solutions. For each prepara-
tion only one of the above drugs was used unless physiological parameters 
indicated that the animal had not deteriorated to any major extent. The 
drug being studied was administered first to the fetus progressing from 
low to high doses (run 1). Following each dose, the blood pressure and 
heart rate were allowed to return to normal or to stable conditions before 
administering the next dose. After completing run 1, the same dosages 
were given but this time progressing from high to low (run 2). This 
procedure was used to determine if the dosing sequence significantly 
altered the magnitude of the drug response. After both run 1 and run 2 
had .been completed in the fetus, the same procedure was performed on 
the mother. In the fetus, the largest volume of drug administered was 
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100 pl which was flushed into the animal with 200 µl of physiological 
saline. When a volume of 300 µl saline was given to the fetus over a 
5-10 second period, no effect was seen. The largest volume of drug 
administered to the mother was one ml followed by one ml of saline. 
Again, when an equivalent volume of physiological saline was given, the 
maternal cardiovascular parameters were unaffected. 
Prior to each run in both mother and fetus, approximately one ml of 
maternal blood was obtained to determine gas tensions and pH, in order 
to assess the status of the preparation. After completing all drug 
injections, the animals were killed by administering a lethal dose of 
magnesium sulfate intravenously. During an experiment, the fetal weight 
was estimated by sight for drug administration. Upon termination, the 
fetus was removed and weighed for accurate determination of the dosages 
used. 
In Vitro Experiments 
To further characterize the relationship between maternal and fetal 
responses to vasoactive drugs, investigation of the alpha-adrenergic 
receptors of the thoracic aorta and cardiac beta-adrenergic receptors 
was undertaken using isolated tissue techniques. 
To obtain the tissues, an adult pregnant animal within one week of 
term was killed by decapitation. The thoracic cavity was opened and the 
heart and thoracic aorta removed and transferred innnediately to a modi• 
fied Krebs-Henseleit salt solution (Krebs, Appendix A). The Krebs solu-
tion was aerated with 95 percent oxygen, 5 percent carbon dioxide. With-
out delay the maternal abdominal cavity was opened exposing the uterus. 
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The uterus was cut open, and the hearts and thoracic aortas of two 
fetuses were removed and transferred to a beaker of oxygenated Krebs 
solution. Each blood vessel was placed in a petri dish, and a metal rod 
of approximately 0.5 mm diameter was passed through the lumen. While 
keeping the blood. vessel submerged at all times, microsurgical scissors 
were used to helically cut each blood vessel into a strip, starting at 
the cardiac portion and proceeding distally. After each blood vessel 
had been cut, two strips of approximately one cm each were prepared by 
cutting the original strip into two parts. To each strip a small loop 
of suture material was tied around one end to anchor the strip to the 
tissue holder. The other end of the strip was secured with suture 
material to an isotonic transducer. Isotonic contractions were registered 
on a Beckman R-611 Dynograph recorder. Each strip was transferred to a 
10 ml isolated tissue bath containing Krebs solution and aerated with 
95% o2:5% co2 and maintained at 37° c. The strips were connected to 
isotonic transducers with a resting tension of one gram for maternal 
segments and 0. 5 grams for the fetal segments. The s.trips were allowed 
to equilibrate for at least one hour or until a steady baseline was 
obtained. 
The method chosen to characterize the alpha adrenergic receptors was 
that of determining the KB or pAx (Schild, 1949; Furchgott, 1972) value 
of the receptor for a specified antagonist. The KB value is the dissoci-
ation constant of the receptor for a specific antagonist and is related 
to pAx as follows: when a dose ratio (x) of two is chosen, the negative 
log of KB is equal to the pA2 value. The procedures used to determine 
pA2 values of drug receptors were the same as those discussed by Furchgott 
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(1972). The formula used to calculate the pA2 values is indicated 
below: 
[A I l /[A] - 1 = [Bl /KB (g. _!.; Furchgott, 1972) 
where B is the concentration of antagonist to which the tissue is exposed; 
[A] is the concentration of agonist required to produce a given control 
response; [A'] ·is the concentration of agonist required, in the presence 
of the antagonist, to produce a response equivalent to .the control 
response; and [A']/[A] is the dose ratio. When these three values are 
known, the KB can be calculated. Equation 1 can be manipulated to give: 
log (dose ratio - 1) = log [BJ - log ~ ~- 1; Furchgott, 1972) 
Equation 2 in turn can be written as: 
log (x-1) = (log l/~) - pAx ~· 1; Schild, 1949) 
From equation 3, it can be seen that if x = 2, then 
Therefore, from an experiment, the KB can be calculated using equation 1. 
This can then be converted into a pA
2 
value using equation 4. 
For a reliable determination of pA
2 
values, the following conditions 
should be satisfied (Furchgott, 1967}. 1) The agonist should act directly 
on the receptor in question and not produce any of its effect by indirectly 
liberating endogenous catecholamines in the test system. 2) The capacity 
of other types of receptors in the effector system to be activated by the 
agonists should be eliminated or made negligible. Thus, if responses 
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mediated by alpha-adrenergic receptors are being studied, the beta-
adrenergic receptors should be blocked; if responses mediated by beta 
receptors are being measured, the alpha receptors should be blocked. 
3) All processes other than passive diffusion which effectively remove 
any of the agonist from the region of the receptors should be blocked. 
4) The agonist concentration in the fluid perfusing the effector system 
should be known and maintained at a fixed level for a period long enough 
to obtain the maximum response to the concentration used. 5) An experi-
mental design should be used such that any change in sensitivity of the 
effector system to the agonist during the course of an experiment is 
apparent and corrected for. 6) Sufficient data should be obtained for 
the plotting of accurate and reliable partial or complete concentration-
response curves of the agonist. 
To meet these requirements set forth by Furchgott (1967), the 
experiments were carried out in the following manner after the initial 
equilibration period. All vessels were contracted with a single dose 
of norepinephrine giving a final bath concentration of 3 x 10-B M. The 
vessels were then washed with fresh Krebs solution, and the monoamine 
oxidase inhibitor iproniazid phosphate was added to give a final bath 
.concentration of 100 pg/ml. After 15 minutes, propranolol (3 x 10-7 M) 
was added to block the beta-adrenergic receptors. After the tissues 
had been in contact with the iproniazid for 45 minutes, they were rinsed. 
Then the propranolol was once again added. At this time, tropolone HCl 
-5 6 
(3 x 10 M) and cocaine HCl (3 x 10- M) were added to inhibit cate-
cholamine-o-methyl transferase and neuronal uptake of norepinephrine, 
respectively. After 15 minutes contact time with cocaine, tropolone, 
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and propranolol, cumulative doses of norepinephrine were administered in 
-9 -6 
half log increments over the range of 1 x 10 M to 1 x 10 M. When 
the final dose of norepinephrine had attained its maximal effect, the 
tissues were washed with fresh Krebs solution and allowed to relax to 
baseline. 
All agonists were made up fresh in physiological saline for each 
experiment from stock solutions of 1 x 10-Z M which in turn were made 
fresh every week and stored. in a freezer. The drugs were administered 
to the baths using lambda pipets to obtain the specified bath concentra-
tions given above. After the tissues reached baseline, the same protocol 
was repeated but this time omitting the iproniazid. Both segments from 
one fetal vessel were equilibrated with the desired phentolamine concen-
tration for 90 minutes prior to administering norepinephrine. Segments 
of the second fetal vessel were time controls, substituting physiological 
saline for phentolamine. One maternal vessel segment was treated and the 
.other segment was used as a time control. The time control allows one 
to determine the change in sensitivity of the tissue to the agonist 
throughout the experiment. This is taken into account when calculating 
the degree of antagonism by phentolamine. 
To obtain dose response curves, the magnitude of the contraction 
of each segment resulting from 1 x 10-6 M norepinephrine in the first 
cumulative dose series was used as a maximum, and all other contractions 
were taken as a percent of this maximal contraction. Dose response 
curves were constructed by plotting log
10 
of the drug concentration on 
the X-axis and. percent maximal contraction on the Y-axis. Although the 
-6 
response to 1 x 10 M norepinephrine is not the absolute maximal 
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contraction that can be obtained, this procedure still allows one to 
work on the linear portion of the dose response curve while avoiding 
desensitization resulting from high doses of norepinephrine. Thus, the 
degree of tissue deterioration is minimized. 
After plotting the dose response curves, the dose which gave SO 
percent contraction (En
50
) in the control and treated was used to deter-
mine the dose ratio of equation 1. This ratio was corrected for the 
change in tissue sensitivity which occurred with time by using the dose 
ratio for the time control. 
At the start of this project, plans were made to characterize the 
atrial beta-adrenergic receptors. The left atria was .trinnned free of 
all other cardiac tissue and suspended in a 10 ml isolated tissue bath, 
perfused with Krebs, and aerated with 95% o2 :S% co2• The experiments 
were conducted at 32.5° C to maintain the integrity of the tissue (Blinks, 
1967). The resting tension for the tissues was between approximately 
70-90 percent of that giving maximal contraction for each tissue. The 
atria were electrically stimulated using either silver or platinum 
electrodes at a rate of 60 min-l in the initial experiments. This was 
reduced to 30 min-l in subsequent experiments. The stimulus strength 
ranged from 10-50 volts. After several experiments during which many 
combinations of the above parameters were tried, I concluded that the 
fetal atria deteriorated too rapidly to allow any reliable data to be 
obtained. This prevented the characterization of the beta-adrenergic 
cardiac receptors. 
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Statistical Analysis 
In vivo -= 
The basal values for maternal and fetal heart rate and blood pressure 
were analyzed using the Students t-test (Snedecor and Cochran, 1967). For 
comparison of the fetal and maternal responsiveness to the drugs tested, 
the slopes of the blood pressure and heart rate dose response curves were 
analyzed (Appendix B). 
In vitro 
= ====-= 
For analysis of the data from the in vitro experiments, the ED
50 
and 
pA2 values for each experiment were calculated. The means were calculated, 
and the Students t-test was used for test of significance (Snedecor and 
Cochran, 1967). · 
Equipment and Chemicals and Their Manufacturers 
Drugs and chemicals 
Acetylcholine and sodium heparin 
Cocaine HCl 
Iproniazid phosphate 
Isoproterenol and phenylephrine 
Lidocaine HCl 
Methoxyflurane 
Norepinephrine HCl 
Phentolamine 
Propranolol 
Sodium chloride 
Sodium heparin 
Sodium thiopental 
Sigma Chemical Co. 
Merck and Co., Inc. 
Hoffman-Laroche Inc. 
Sterling-Winthrop Research Institute 
Interstate Drug Exchange 
Pitman-Moore Inc. 
Calbiochem 
Ciba Chemical Co. 
Imperial Chemical Co. 
Fisher Scientific Co. 
Interstate Drug Exchange 
Diamond Laboratories 
Tropolone 
95% 02:5% co2 gas mixture 
Equipment 
Handilead ring 
Isolated tissue baths 
Isotonic transducers (Model 
33-03-981) 
Lambda pipets 
Microsurgical scissors 
pH/Blood Gas Analyzer 513 
Physiological pressure transducer 
(Type 4-327-0121) 
Polyethylene tubing 
R-611 dynograph recorder and 
tachograph coupler (Type 9857B) 
Suture material 
Thermal pad 
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Aldrich Chemical Co., Inc. 
Union Carbide Corp. 
Instruments for Research & Industry 
Metroware 
Gould Inc. 
H. E. Pederson 
Roboz Microsurgical Instrument, Inc. 
Instrumental Laboratories 
Bell and Howe 
Intramedic Corp. 
Beckman Instrument Inc. 
Ethic on, Inc. 
Gorman Rupp Industries 
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RESULTS 
.!!! Vivo Experiments 
Two classes of in vivo experiments were cond.ucted for this project. 
In one class, pentobarbital sodium was used as the anesthetic. In the 
other class, the experiments were carried out under methoxyflurane 
anesthesia. For these two classes of experiments, the basal heart rates 
and mean arterial blood pressures are presented in Table 1. 
Table 1. Mean arterial blood pressure (MABP) and heart rate under 
pentobarbital and methoxyflurane anesthesia 
MABP (mm Hg) 
-1 Heart rate (min ) 
MABP (mm Hg) 
-1 Heart rate (min ) 
aA (pentobarbital, n = 6). 
b 
Mean + SE. 
c B (methoxyflurane, n = 15). 
* 
Fetal 
33.2± o.8b* 
232.5 + 10.4 
* 28.1 + 1.1 
* 197.2 ± 5.7 
Maternal 
* 54. 3 + 1.1 
257.0 ± 10.2 
* 43.8 + 1.6 
* 223.0 + 8.7 
Maternal significantly different than.fetal (p < 0.05). 
Basal fetal and maternal arterial blood pressures under pentobarbital 
anesthesia were significantly different (p < 0.05) while the basal heart 
rates were similar (p > 0.05). Under methoxyflurane, both basal mean 
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arterial blood pressure and basal heart rate of the fetus were signif i-
cantly different from those of the mother (p < 0.05). The values in 
Table 1 compare with values found in the literature of 57 mm Hg and 
·259 min-l for the adult mean arterial blood pressure and heart rate, 
respectively (Marshall and Hanna, 1956). For term fetal guinea pigs, 
no values could be found in the literature for arterial blood pressure, 
-1 but a value of 189 min has been reported for heart rate (Biological 
Handbooks, Respiration and Circulation, 1971). 
For each drug tested in vivo, the data are expressed as percent 
change from basal values for mother and fetus because of the different 
initial basal values for mother and fetus. After transforming the data 
into linear functions, regression formulas were derived to describe the 
responses. These formulas were used to construct the graphs and test 
for similarity of slope between maternal and fetal responses. 
The heart rate and blood pressure responses of the mother and fetus 
in response to norepinephrine administration under pentobarbital anesthe-
sia are shown in Figures 3 and 4. In all cases, norepinephrine resulted 
in an increase in heart rate and blood pressure. Both the regressions 
describing heart rate changes and those describing blood pressure were 
'' 
significantly different between maternal and fetal groups (p < 0.05). 
The slope of the maternal response was greater for both heart rate and 
blood pressure. Within the fetal group, the regressions describing the 
fetal heart rate response possessed a cominon slope (p > 0.05) and, 
likewise, the fetal blood pressure response possessed a common slope 
among animals (p < 0.05). For the regressions describing maternal heart 
rate responses to norepinephrine, a common slope was not present among 
Figure 3. Percent change in mean arterial blood pressure (MABP) in 
response to norepinephrine (NE) administration under 
pentobarbital anesthesia, for 6 experiments 
A entire fetal dose response curve 
B .lower portion of fetal dose response curve 
C entire maternal dose response curve 
I individual 95 percent confidence limits 
observed value 
0 two points indicated 
A niore than two points indicated 
e predicted value 
Fetal regression: y = -82.2 + 106.9 10Jdose 
S.E. 'slope= 8.4, S.E. intercept= 9.4, coefficent of 
determination: (r2) = 0.67 
Maternal regression: y = -175.0 + 255 .. 9 1~dose 
S.E. slope = 25.9, S.E. intercept = 23.8, coefficient 
of determination: (r2) = 0.68 
Control fetal blood pressure: 33.2 ± 0.8 mm Hg 
Control maternal blood pressure: 54 .. 4 :!: 1.1 mm Hg 
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Figure 4. Percent change in heart rate in response to norepinephrine 
(NE) under pentobarbital anesthesia, for 6 experiments 
A entire fetal dose response curve 
B lower portion of fetal dose response curve 
C entire maternal dose response curve 
I individual 95 percent confidence limits 
observed value 
0 two points indicated 
6 more than two points indicated 
e predicted 
Fetal regression: y = -24.1 + .34.7 1~dose. 
S.E. slope = 4.4, S.E. intercept = 4.9, coefficient 
of determination (r2) = 0.45 
Maternal regression: y = -34 •. 7 + 48.5 1~dose. 
S.E. slope= 0.61, S .• E. intercept = 5.6, coefficient 
of determination (r2) = 0.58 
Control fetal heart rate: -1 232 min 
Control maternal heart rate: -1 257 min 
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the animals (p < 0.05). While the regressions describing maternal blood 
pressure did possess a connnon slope (p > 0.05). Each animal had differ-
ent y intercepts so no analysis could be performed to test for likeness 
of maternal and fetal intercepts for any of the drugs used. 
Norepinephrine administration under methoxyflurane anesthesia, as 
with pentobarbital anesthesia, increased both maternal and fetal heart 
rate and blood pressure. The recordings and data are presented in 
Figures 5-7. The slopes describing heart rate and blood pressure 
responses were both significantly different between mother and fetus 
(p < 0.05). Tests were performed to determine the presence of connnon 
slopes within fetal and within maternal heart rate responses. Tests 
were also done within fetal and within maternal blood pressure responses. 
Neither blood pressure nor heart rate responses to norepinephrine within 
the fetal group cou.ld be described by a single slope (p < 0.05). However, 
the heart rate and blood pressure responses within the maternal group 
could each be described using a connnon slope for each of the parameters 
(p > 0.05). An important point that should be brought out is that, 
although the magnitude of the response and slopes of the maternal and 
fetal regressions differ, the dose to produce a threshold effect was 
similar in both mother and fetus as shown by the plots. 
When examining the actual recordings, Figure 7, some important 
aspects should be noted. First is the transient plateau in the fetal 
blood pressure response when high doses were administered to the fetus. 
Second is the fact that, when norepinephrine was given to the mother, a 
transient fetal bradycardia and hypotensiori occurred. 
Figure 5. Percent change in mean arterial blood pressure (MABP) in 
response to norepinephrine (NE) administration under 
methoxyflurane anesthesia, for 3 experiments 
A fetal dose response curve 
B maternal dose response curve 
I individual 95 percent confidence limits 
observed value 
0 two points indicated 
A more than two points i'ndicated 
e predicted 
Fetal regression: y = -11.9 + 39.9 f:.;~a~o~s-e-. 
S.E. slope= 3.1, S.E. intercept= 3.9, coefficient 
of determination (r2) = 0.79 
. 4~~ Maternal regression: y = -48.7 + 170.7 ..,)dose. 
S.E. slope = 15.3, S.E. intercept = 11.9, coefficient 
of determination (r2) = 0.81 
Control fetal blood pressure: 28.1 ± 1.1 nnn Hg 
Control maternal blood pressure: 43 .8 ± 1. 6 nnn Hg 
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Figure 6. Percent change in heart rate in response to norepinephrine 
(NE) administration, under methoxyflurane anesthesia, for 
3 experiments 
A, fetal dose response curve 
B maternal dose response· curve 
I 95 percent confidence limits 
observed value 
0 two points indicated 
11 more than two points indicated 
e predicted 
Fetal regression: y = -1.7 + 11.5 ::;dose. 
S.E. slope = 1.3, S.E. intercept = 1.6, coefficient 
of determination (r2) = O. 68 
Maternal regression: y = -5. 7 + 18. 0 ':.J dos~. 
S,E, slope= 2.5, S.E. intercept= 1.9, coefficient 
of determination (r2) = 0.66 , 
Control fetal heart rate: 
-1 
197 min 
Control maternal heart rate: 
-1 
223 min 
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Figure 7. Recording of blood pressure and heart rate during norepinephrine 
administration under methoxyflurane anesthesia; arrow indicates 
.time of injection 
.A fetal administration 
B maternal administration 
MBP maternal blood pressure 
MHR maternal heart rate 
FBP fetal blood pressure 
FHR fetal· heart rate 
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The maternal and fetal responses to acetylcholine under methoxy-
flurane anesthesia are presented in Figures 8-10. In both mother and 
fetus, a decrease in mean arterial blood pressure and an increase in 
heart rate resulted from acetylcholine administration. The slope of 
the regression equation describing maternal blood pressure response was 
significantly greater than the slope of the regression describing the 
fetal blood pressure response (p < 0.05). A common slope existed within 
the maternal blood pressure responses to acetylcholine (p > 0.05). The 
fetal blood pressure responses to acetylcholine were not as consistent 
as the maternal responses.· A common slope describing the fetal blood 
pressure changes was not present (p < 0.05). The slope describing the 
maternal heart rate response to acetylcholine was also significantly 
greater than that of the fetus (p < 0.05). Neither within the fetal 
group nor within the maternal group were common slopes able to describe 
the heart rate changes (p < 0.05). 
The results of the alpha-adrenergic agonist, phenylephrine, are 
presented in Figures 11-13. Phenylephrine increased blood pressure in 
both mother and fetus. The slope of the regression equation describing 
maternal blood pressure response was significantly greater (p < 0.05) 
than the slope describing fetal blood pressure response. A connnon slope 
was not present among the regression equations describing the blood 
pressure changes of the fetuses (p < 0.05). Nor did a common slope 
exist among the regression equations describing the maternal blood pres-
sure changes (p < 0.05). Not only were the regression equations describ-
ing maternal and fetal heart rate responses to phenylephrine significantly 
different in magnitude (p < 0.05), the slope was negative in the maternal 
Figure 8. Percent change in mean arterial blood pressure (MABP) 
in response to acetylcholine (ACH) .administration, under 
methoxyflurane anesthesia, for 5 experiments 
A fetal dose response curve 
B maternal dose response curve 
I 95 percent confidence limits 
observed value 
6 more than two points indicated 
e predicted 
Fetal regression: y = -18.9 - 8.7 (log dose). 
S.E. slope = 8.3, S.E. intercept = 1.1, coefficient 
of determination (r2) = 0.61 
Maternal regression: y = -32.8 - 13.4 (log dose). 
S.E. slope= 0.95, S.E. intercept= 1.14, coefficient 
of determination (r2) = 0.77 
Control fetal blood pressure: 28.1 ± 1.1 mm Hg 
Control maternal blood pressure: 43.8 ± 1.6 mm Hg 
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Figure 9. Pe,cent change in heart rate in response to acetylcholine 
(ACH) administration under methoxyflurane anesthesia, for 
5 experiments 
A fetal dose response curve 
B maternal dose response curve 
I 95 percent confidence limits 
observed value 
11 more than two points indicated 
e predicted 
2---Fetal regression: y = 0.59 + 0.94 ~dose. 
S.E. slope = 0.94, S.E. intercept = 0.59, coefficient 
of detennination (r2) = 0.49 
Maternal regression: y = 0.24 + 1.11 ,:;dose. 
S.E. slope= 0.12, S.E. intercept= 0.45, coefficient 
of detennination (r2) = 0.61 
Control fetal heart rate: 
-1 
197 min 
Control maternal heart rate: -1 233 min 
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·Figure 10. Record;i.ng of blood pressure and heart rate during acetylcholine 
adminis.tration under methoxyflurane anesthesia; arrow indicates 
time of injection 
A fetal administration 
B maternal administration 
MBP maternal blood pressure 
MHR maternal heart rate 
FHR fetal heart rate 
FBP fetal blood pressure 
:] ............ Time (sec.I MBPmmHg ,........, 
0 60. 
FBP mmHg ~~ • ~~ .. a A I I I ' I I 
MHAmln"1 300] 
160 
FHA mlri1 300] ------+- ___,......._._ 160 Acetylchollne 
0..3 1.0 1.0 30.0 10.0 µg,kg 
"' CXl
50] .,....,...~~ MBPmmHg 25 
B FBP nvnHg =~ ~ MHAmlri1 30~ I· 180 
FHA mlri1 300] 
180 
0.3 1.0 1.0 30.0 10.0 
Figure 11. Percent increase in mean arterial blood pressure (MABP) 
in response to phenylephrine (PE) administration under 
methoxyflurane anesthesia, for 5 experiments 
A fetal dose response curve 
B maternal dose response curve 
I 95 percent confidence limits 
observed value 
~ more than two points indicated 
e predicted 
Fetal regression: y = -2.45 + 5 .. 8 ~~a~o-s-e-. 
S.E. slope= 5.18, S.E. intercept= 2.45, coefficient 
of determination (r2) = 0.85 
Maternal regression: y = 123 + 16.7 '.:/aose. 
S,E; slope = 1.1, S.E. intercept = 4.9, coefficient 
of determination (r2) = 0.79 
Control fetal blood pressure: 28.1 ± 1.1 mm Hg 
Control maternal blood pressure:. 43.8 ± 1,6 mm Hg 
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Figure 12. Percent change in heart rate in response to phenylephrine 
(PE) administration under methoxyflurane anesthesia, for 
5 experiments 
A ·fetal dose response curve 
il maternal dose.response curve 
I 95 percent confidence limits 
observed value 
0 two points indicated 
6 more than two points indicated 
e predicted 
Fetal regression: y = -1.58 + 0.78 :,,dose. 
S .• E. slope= 0.16, S.E. intercept= 0.91, coefficient 
of determination (r2) = 0.26 
Maternal regression: y = 1.25 - 1.32 ~~a~o-s-e-. 
S.E. slope= 0.04, S.E. intercept= 1.72, coefficient 
of determination (r2) = 0.16 
Control fetal heart rate: 197 
Control maternal heart rate: 
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-1 
223 min 
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Figure 13. Blood pressure and heart rate recording during phenylephrine 
administration under methoxyflurane anesthesia; arrow indicates 
time of injection 
A fetal administration 
B maternal administration 
MBP maternal blood pressure 
MHR maternal heart rate 
FBP fetal blood pressure 
FHR fetal heart rate 
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group and positive in the fetal group. When tests for conunon slopes 
for the regression eq~ations within the mothers and within the fetal 
groups were performed, no conunon slope for either group was found 
(p < 0.05). Inspection of the data indicated that the fetal group could 
be divided into those which respond to phenylephrine administration with 
an increase in heart rate and those which respond with a slight decrease 
in heart rate (p < 0.05). Although a conunon slope for the regressions 
describing the maternal heart rate responses to phenylephrine was not 
apparent, there did not appear to be two distinct groups as seen with 
the fetuses. 
The above information regarding the overall heart rate response to 
phenylephrine should be kept in mind when examiriing the recordings in 
Figure 13. Despite the increase in fetal blood pressure when phenyl-
ephrine was given directly to the fetus, little reflex fetal bradycardia 
was seen. In contrast, reflex .maternal bradycardia was pronounced when 
phenylephrine was given to the mother. Following the phenylephrine 
induced increase in maternal blood pressure, there occurred a fetal 
bradycardia (Figure 13). This response was not observed when comparable 
doses were administered directly to the fetus. These events are similar 
to those mentioned previously regarding norephinephrine (Figure 7). 
Responses to isproterenol are shown in Figures 14 and 15. Fetal 
responses were very inconsistent. Arrhythmias and cardiac arrests were 
frequent. This is illustrated at the dose of 3.0 pg/kg in Figure 14. 
A sufficient amount of data regarding heart rate and blood pressure 
changes in response to isoproterenol could not be collected to allow 
quantitative analysis. From a qualitative standpoint, it can be seen 
Figure 14. Recording of blood pressure and heart rate during isoproterenol 
administration under methoxyflurane anesthesia; arrow indicates 
time of injection 
A fetal administration 
B maternal administration 
MBP maternal blood pressure 
MHR maternal heart rate 
FBP fetal blood pressure 
FHR fetal heart rate 
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Figure 15. Recording of maternal arterial blood pressure (MBP) and 
heart rate (MHR) during isoproterenol injection under 
methoxyflurane anesthesia; arrow indicates time of 
injection 
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l from the recordings that in some mothers isoproterenol produced a transi-
ent decrease in mean arterial blood pressure, Figure 15, while in others 
only an increase in blood pressure was seen, Figure 14. 
None of the drugs used in vivo showed a distinct difference in the 
duration of action between mother and fetus. 
The modifying effects of atropine on basal heart rate and mean 
arterial blood pressure for the mother and fetus are shown in Table 2. 
The effectiveness of the atropine blockade was determined by its ability 
to prevent a decrease in blood pressure following the i.v. administration 
of 5.0 pg/kg of acetylcholine. In both types of anesthesia, a significant 
increase in basal fetal heart rate was seen after the administration of 
atropine (p < 0.05). The mothers responded to atropine with an increase 
in basal heart rate but this was not statistically significant (p > 0.05). 
The mean arterial blood pressure for both mother and fetus was not sig-
nificantly altered by atropine (p > 0.05). In addition, the heart rate 
and blood pressure responses of the mother and fetus to norepinephrine 
were not significantly (p > 0.05) altered by the presence of atropine. 
In Vitro Experiments 
In order to obtain information which would assist in explaining the 
cause of decreased fetal responsiveness to biogenic amines in ~' 
in vitro experiments were perfornied. In four experiments, the tissues 
were contracted to norepinephrine using a cumulative dose response series 
(Figure 16). The sensitivity difference between maternal and fetal 
vessels to norepinephrine, determined from the En
50 
values (Table 3), 
was nonsignificant (p > 0.05). 
Table 2. Effects of atropine (1 mg/kg) on basal mean arterial blood pressure (MABP) and heart rate 
during pentobarbital and methoxyflurane anesthesia 
Pentobarbital 
(n = 6) 
Methoxyflurane 
(n = 5) 
-
MABP (mm Hg) 
-1 
Heart rate (min ) 
MABP (mm Hg) 
Heart rate 
-1 
(min ) 
~ean + S.E. 
* 
Before atropine 
Fetal Maternal 
30.0 + 1.la 55.9 + "4.5 
224.0 + 3.3 268.5 + 10.3 
26.9 + 0.3 44.8 + 0.9 
207.0 + 0.8 195.0 + 1.2 
After atropine 
Fetal Maternal 
30. 9 ± 1.1 53.5 + 4.5 
254.5 + 3.3* 276.0 ± 10.3 
26.6 + 0.3 43.9 + 0.9 
217.0 + 0.8* 198.0 + 1.2 
Indicates significant (p > 0.05) difference in values before and after atropine. 
..... 
0 
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Table 3. Norepinephrine ED50 values for the thoracic aorta 
Experiment Fetal Maternal 
1 3.5 x 10-7 M 4.0 x 10-7 M 
2 2.2 x 10-7 M 3.1 x 10-7 M 
3 5.8 x 10-7 M 2.5 x 10-7 M 
4 5.6 x 10-7 M 2.5 x 10-7 M 
Mean ± S.E. -7 4.3(± 1.8) x 10 M -7 3.0(± 0.4) x 10 M 
Phentolamine was used as the alpha-adrenergic antagonist for deter-
mining pA2 values in six experiments. The dose response curves from one 
experiment are shown in Figures 17 and 18. The curves were constructed 
using the contraction caused by 1 x 10-6 M norepinephrine as maximal con-
traction. For the maternal vessels, the pA
2 
values were obtained using 
-7 a phentolamine concentration of 3 x 10 M. For the fetal vessels, a 
phentolamine concentration of 1 x 10-6 M was used. 
With the info:anation described preyiously in the methods section, 
the pA2 values were calculated (Table 4). The unpaired students t-test 
revealed no significant difference (p > 0.05) between maternal and fetal 
pA
2 
values. 
From a qualitative aspect, the following observations were made as 
a result of the i.!! vitro experiments. The fetal vessels generally showed 
a high level of spontaneous activity during the equilibration period. 
Throughout the experiments, a difference was observed in the rate and 
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Figure 16. Dose response curves of thoracic aorta from one 
experiment in response to cumulative doses of 
norepinephrine (NE) 
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Figure 17. Fetal dose response curves to norepinephrine (NE) 
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Figure 18. Maternal dose response curves to norepinephrine (NE) 
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Table 4. Phentolamine pA2 values on the thoracic aorta 
Experiment Fetal Maternal 
1 7.8 7.9 
2 7.8 7.6 
3 7.7 7.3 
4 7.5 7.4 
5 7 .5 7.8 
6 7.5 7.8 
Mean ± S. E. 7.6 + 0.06 7.6 + 0.10 
typ~ of contractions elicited by norepinephrine in maternal and fetal 
vessels. The fetal vessel contracted more slowly than the maternal. In 
addition, the fetal vessels often contracted in a step-like manner in 
response to the lower norepinephrine concentrations as opposed to the 
smoot.h continuous contractions throughout this concentration range of 
the maternal vessels. This is shown in Figure 19 which is a tracing from 
an actual record. 
A~·_// . 
I / I 
3 4 5 6 
B 
f I 
3 4 
7 
I 
8 
76 
I 
9 
1 min. 
Figure 19. Recording of isotonic contractions of fetal (A) and 
maternal (B) thoracic aorta to norepinephrine. Code 
for final bath concentration of norepinephrine: 
3 = 1 x lo-9·M 4 = 3 x lo-9 5 = 1 x lo-8 6 = 
3 x lo-8, 7 =ix 10~7, 8 = j x lo-7, 9 =ix lo-6 
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DISCUSSION 
The proper choice of anesthetic is well-illustrated by the difference 
in basal cardiovascular parameters resulting from the use of pentobarbital 
when compared to the values for the same parameters under methoxyflurane 
anesthesia. The elevated values for basal heart rate and mean arterial 
blood pressure during pentobarbital when compared to methoxyflurane values 
are most likely the result of abolishment of central vagal inhibition 
(Assali et al., 1974). During pentobarbital anesthesia, the basal fetal 
heart rate and blood pressure were both 18 percent higher than the value 
obtained during methoxyflurane anesthesia. Likewise, the maternal basal 
heart rate was 15 percent higher, and basal blood pressure was 24 percent 
higher during pentobarbital anesthesia as compared to heart rate and 
blood pressure measured during methoxyflurane anesthesia. The fact that 
heart rate and blood pressure increases were comparable in the fetus while 
the maternal blood pressure increase was greater than the heart rate 
increase suggests that blood pressure control in the fetal guinea pig 
is different from control of blood pressure in the mother. The develop-
mental lag in peripheral innervation as c6mpared to cardiac innervation 
in the fetus may be one reason for the altered control of fetal blood 
pressure in comparison to the maternal blood pressure (Wyse et al., 1976; 
Harris and Van Petten, 1978). This lack of functional innervation sug-
gests that neural control of blood pressure in the fetus is mediated 
primarily by changing the heart rate rather than peripheral vasomotor 
tone. In the mother, where peripheral neural circulatory control is 
present, the blood pressure may be dually regulated by a change in either 
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cardiac output and/or peripheral resistance. 
The cited literature values for basal heart rate and blood pressure 
of 269 min-l and 57 mm Hg for maternal and 189 min-l for fetal were 
obtained during pentobarbital, ether, or local anesthesia using procaine 
(Marshall and Hanna, 1956; Biological Handbook, Respiration and Circula-
tion, 1971). The data from my pentobarbital experiments agree well with 
the literature values. 
The lower fetal guinea pig hea.rt rate in comparison to the adult is 
contrary' to the data from sheep experiments and values for humans (Joelsson 
et al., 1972; Assali et al., 1977; Klophenstein and Rudolph, 1978; Schif-
ferli and Caldeyro-Barcia, 1973). It does, however, agree with other 
data collected on fetal guinea pigs which indicate a heart rate at mid 
1 -1 
gestation of 165 min- , a rate of 189 min at 50 days gestation, and a 
rate of 289 min-l in the newborn; Again, pentobarbital was used as the 
anesthetic in attaining these values cited in the literature (Biological 
Handbooks, Respiration and Circulation, 1971). Pentobarbital significantly 
increased (p < 0.05) the fetal heart rate in my experiments when compared 
to the values obtained under methoxyflurane anesthesia. One of the actions 
of pentobarbital is to attenuate cardiomotor vagal tone whereas metho-
xyflurane leaves the heart rate unaltered except during deep anesthesia 
(North et al., 1961). One might suggest that the elevated basal heart 
rate under pentobarbital when compared to methoxyflurane is a result of 
elimination, by pentobarbital, of a large. amount of the inhibitory cardiac 
vagal tone normally present in the term guinea pig. Some may consider 
the lower basal fetal heart rate in comparison to that of the adult to be 
the result of fetal asphyxia. These experiments were performed with the 
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animals in dorsal recumbency which could occlude the caval veins, thereby 
decreasing blood flow to the uterus (Moir, 1976). Although the maternal 
blood gases and pH were normal, there may have been insufficient blood 
flow to the placenta resulting in fetal asphyxia. This asphyxia can lead 
to fetal myocardial depression which results in terminal bradycardia 
(Rosen, 1976). However, it is unlikely that fetal asphyxia was the cause 
of the decreased fetal heart rate in my experiments for the following 
reasons. 1) If caval occlusion was present, the decreased venous return 
would require an increased maternal heart rate to maintain cardiac output. 
No increased maternal heart rate occurred in my experiments when compared 
to the values found in the literature. 2) My preparations lasted for 
several hours without fetal heart rate or blood pressure showing ariy 
signs of deterioration. 3) During initial experiments, fetal electro-
cardiograms were recorded and no arrhythmias appeared. 
The low basal fetal blood pressures in comparison to adult values 
are in agreement with data from other fetal experiments (Joelsson et al., 
1972; Assali et al., 1977). There are several possible reasons for low 
fetal blood pressures. They are partially the result of low resistance 
shunts present in the fetal circulatory system and umbilical-placental 
circulation. In addition, the lack of functional sympathetic innervation 
to the peripheral vasculature (Wyse et al., 1976; Harris-and Van Petten, 
1978) thereby decreasing systemic resistance may of fer another 
explanation. Increased quantities of circulatory vasodepressor 
agents in the fetus but not in the adult is another possibility and is 
substantiated by the finding that fetal vessels have a greater ability 
to synthesize the vasodilator prostacyclin (Terragno et al., 1978). 
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Keeping in mind that fetal cardiac output is approximately twice that of 
an adult (Rudolph and Heymann, 1974) and that cardiac output is propor-
tional to arterial pressure/peripheral resistance, then whatever factors 
causing decreased fetal blood pressure must be working by drastically 
decreasing the resistance of the fetal vascular system. 
Along with low fetal blood pressure, a decreased fetal responsive-
ness compared to maternal responsiveness was seen for all vasoactive 
biogenic amines tested. In both sets of experiments in which norepineph-
rine was administered, the decreased fetal responsiveness, i.e., mean 
arterial blood pressure changes and heart rate changes, agrees with 
results obtained in sheep experiments (Assali et al., 1977). As a result 
of these past experiments, it has been proposed that the magnitude of the 
elevated blood pressure in response to catecholamines was less in the 
fetus than the adult. The ED
50 
values remained the same throughout gesta-
tion (Nuwayhid et al., 1975). This latter statement should not be weighed 
too heavily, remembering that, .!!:! vivo, none of the parameters mentioned 
by Furchgott (1967) for receptor characterization can be controlled in 
the intact animal. Secondiy in most fetal lamb experiments, the drug 
dosages are calculated solely by estimating the fetal weight from gesta-
tional age (Stephenson, 1958). This estimation reduces the accuracy of 
the results if one is evaluating the ED
50 
values. 
Norepinephrine has both alpha- and beta
1
-adrenergic receptor activity. 
Therefore, using solely this drug, it cannot be stated definitively whether 
the decreased fetal pressor response to norepinephrine seen in my experi-
ments is the result of a decreased cardiac sensitivity alone or whether 
the vascular reactivity is also less in the fetus. The results from the 
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phenylephrin(;! experiments serve to answer this question. 
The results of the pure alpha-adrenergic agonist, phenylephrine, 
indicate that decreased fetal responsiveness to catecholamines is partially 
due to decreased peripheral vascular sensitivity. Fetal pulmonary vessel 
walls possess decreased amounts of smooth muscle mass in comparison to 
adult vessels, and hypertension stimulates smooth muscle cell growth 
(Rudolph and Heymann, 1978; Levin et al., 1978). Perhaps the peripheral 
vasculature possesses these same characteristics. If so, the lack of 
peripheral vasoconstriction could be due to a lack of smooth muscle cell 
mass. At birth, with the elimination of the low resistance shunts, an 
increased fetal blood pressure results. Perhaps this increased blood 
pressure stimulates vascular smooth muscle cell growth, thereby increasing 
the constrictive capabilities of the peripheral vasculature (Rudolph and 
Heymann, 1978; Levin et al., 1978). 
A decreased smooth muscle mass is not the only tenable explanation 
of decreased peripheral vasoconstriction. Perhaps the decreased fetal 
arterial oxygen tensions render the vessels incapable of producing a 
large contractile force when excited. Another possible explanation for 
the decreased vasoconstriction would be the presence of a circulating 
vasodepressor in the fetus which would oppose any excitatory effects of 
the vasoconstrictors administered. A possible candidate for such a com-
pound is prostacyclin, as mentioned earlier in this discussion (Terragno 
et al., 1978). 
My results argue against the notion that decreased fetal responsive-
ness to catecholamines as seen in my in~ experiments is the result of 
altered adrenergic receptor affinity. Both the ED50 values and pA2 values 
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'for the alpha-adrenergic receptor of the thoracic aorta were similar 
(p > 0.·05) in the mother and fetus. The pA
2 
value for phentolamine inter-
acting with the alpha-adrenergic receptors of 7.6 arrived at from 
my data, is very similar to that cited in the literature. For the rabbit 
aorta, using phentolamine as the antagonist and phenylephrine as the 
agonist, a pA
2 
value of 7.83 has been reported (Furchgott, 1970). The 
similarity of the affinity of the alpha-adrenergic receptor of maternal 
and fetal guinea pig aorta is supported by data from in vitro experiments 
conducted using fetal lamb vessels (Wyse et al., 1976). 
The cause of the decreased fetal sensitivity to acetylcholine with 
regard to blood pressure and heart rate is unclear. The intestinal mus-
carinic receptors have been shown to have the same pD2 values in the adult 
and fetal guinea pig (Boreus and McMurphy, 1971). This would lead one to 
speculate that the affinity of the muscarinic receptors of the cardio-
vascular system are the same for mother and fetus. A quantitative dif-
ference between maternal and fetal plasma cholinesterase activity has 
been demonstrated in sheep with the activity in the fetus being greater 
(Bell and Van Petten, 1976). If this holds true for the guinea pig, then 
a greater rate of degradation of acetylcholine by the fetus could explain 
the decreased sensitivity to acetylcholine. Another possibility is that 
the fetal vasculature is maximally dilated so that attempts to elicit 
further dilation are ineffective. The effect of acetylcholine on the 
heart is one of negative inotropy and negative chronotropy. The positive 
chronotropy seen in both the mother and fetus in my experiments was most 
likely not the direct effect of acetylcholine. Higher doses than those 
used in these experiments would be required to produce direct cardiac 
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effects which could be monitored. This positive chronotropy could result 
from a baroreceptor reflex which has been shown to be active in fetal 
sheep (Rudolph and Heymann, 1973). The functionality of baroreceptors 
would lend support to the hypothesis of a homeostatic vagal tone 
in the fetus which was presented earlier in the discussion of anes-
thetic effects. However, until further experiments are performed, this 
positive chronotropy seen during acetylcholine administration cannot be 
definitely attributed to the baroreflex. Other possible explanations 
could include a catecholamine release from small intensely fluorescent 
cells (Papka, 1975) or the adrenal medulla. 
The heart rate changes seen in the phenylephrine experiments are 
unusual. There appeared to be either a bradycardia or no effect at all 
on maternal heart rate. However, in the fetus, either a slight negative 
chronotropic or a larger positive chronotropic response was observed. 
Since phenylephrine is classified as a relatively pure acting alpha-
adrenergic agonist, no stimulatory cardiac effects are seen in the adult. 
Yet cardiac excitatory effects appeared in the fetus particularly at 
higher doses. There is evidence that alpha-adrenergic receptor activa-
tion in the guinea pig atria elicits a positive chronotropic response 
(Govier, 1968). In the fetal guinea pig, perhaps this alpha-adrenergic 
receptor stimulation plays a more important role than in the adult. It 
has been shown in fetal rats that beta
1
-adrenergic receptor activation 
results in changes in adenyl cyclase.activity. without inotropic or chrono-
tropic effects (Martin et al., 1973). Perhaps mechanisms beyond receptor 
binding are not well-developed in the fetus. If there is lack of 
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development in the receptor effector mechanism, perhaps alpha-adrenergic 
receptor activation in the fetus results in metabolic changes not occurring 
in the adult. For example, the positive chronotropic and inotropic 
responses seen during beta
1 
stimulation appear to be mediated by increases 
in cyclic AMP levels (Kukovetz and Poch, 1972). If the receptor effector 
mechanism is not well-developed in the fetus, then perhaps alpha-adrenergic 
activation causes a rise in cyclic AMP. This might result in the positive 
chronotropy seen during fetal administration of phenylephrine. However, 
biochemical studies are necessary before any definitive statements can he 
made. Although phenylephrine is classified as a pure alpha-adrenergic 
agonist, high concentrations of the drug can induce nonspecific beta 
receptor activation (Furchgott, 1972) thus leading to excitation of the 
fetal heart. Perhaps this nonspecific receptor activation also occurs 
in the adult. However, it may be physiologically antagonized by a greater 
baroreceptor activity in the adult, thereby preventing the manifestation 
of any cardiac effects. 
It is apparent that a high degree of variability exists especially 
with respect to heart rate responses. So much so that, in some sets of 
experiments, no common slope for the regression on heart rate changes 
either within maternal group or within fetal groups could he found 
(p < 0.05). The duration of injection was kept' as constant as possible. 
However, this time factor could introduce variability. With the ana-
tomical shunts present in the heart and major vessels of the fetus, a 
high percentage of blood returning via the superior vena cava passes 
through the right side of the heart and into the pulmonaryartery. A 
high proportion of blood returning via the inferior vena cava enters 
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the right atria and flows through the foramen ovale and out the left 
ventricle (Dawes, 1968; Joelsson et al., 1972). Therefore, positioning 
of the jugular cannula and force of injection could alter the amount of 
drug that the heart is exposed to at a given dose. The lack of connnon 
slopes for either maternal or fetal heart rate changes may also result 
from a difference in the level of baroreceptor activity which is attempt-
ing to return the heart rate and blood pressure to normal. This baro-
receptor activity as with many reflexes can be depressed by the use of 
anesthetics. Throughout each experiment, the anesthetic concentration 
had to be adjusted in an attempt to keep the animal properly a?esthetized. 
For some experiments, perhaps the baroreceptor reflex was depressed to 
different extents. This would give rise to different degrees of vagal 
inhibition to the heart for a given increase in blood pressure. 
Finally, with respect to the difference in magnitude of heart rate 
response within groups, is the fact that mouse atria, human ventricular 
tissue, and fetal sheep show an increasing magnitude of response to nor-
epinephrine and acetylcholine as gestation progresses (Wildenthal, 
1973; Nuwayhid et al., 1975; Coltart and Spilker, 1972). Rates of fetal 
maturation do vary, and a difference of a few days in gestational age 
may cause a significant difference in the guinea pig from a developmental 
standpoint. Although the guinea pigs were used at 60 ± 2 days gestational 
age, perhaps there was a difference in the level of fetal development 
among animals thus altering the degree of responsiveness to drugs. 
The fact that for some drugs common slopes were not present for 
heart rate and blood pressure changes within either a fetal or maternal 
group did not invalidate the fact that the slopes describing the overall 
-. 
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responses were different between mothers and fetuses. The lack of a 
common slope within groups was generally due to the unusual responses of 
one or two animals in the group. When tests of significance were done 
for each separate experiment, a significant difference between mother 
and fetus almost always appeared, except for the heart rate changes in 
response to norepinephrine under pentobarbital anesthesia. When the data 
from all of the animals for a specific drug were pooled, the difference 
between mother and fetuses generally became more significant. 
With the rise in fetal blood pressure resulting from phenylephrine 
administration, very little or no reflex fetal bradycardia occurred. 
Comparing this to the acetylcholine effects, it seems to indicate that 
the fetal baroreceptors are responsive to hypotension but not hypertension. 
The literature states that the baroreceptors in fetal lambs are functional 
at 0.55 gestational age (Rudolph and Heymann, 1973). These fetal lamb 
experiments were conducted on unanesthetized lambs i!!_ utero, which could 
explain .the discrepancy between their findings and mine. Another possible 
cause of this discrepancy is that of interspecies differences. 
The fact that the administration of atropine to the preparation 
resulted in an increase in basal heart rate of the fetus and not the 
mother may possibly be explained in the following manner. Consider the 
fact that pentobarbital anesthesia decreases vagal tone (Assali et al., 
1974) as mentioned previously in this discussion. Also bear in mind the 
fact that the fetal plasma concentration of pentobarbital is less than 
that of the mother (Boulos et al., 1971). In this situation, the fetal 
vagal cardiac reflexes would not be depressed as much as the maternal 
reflexes. This would allow for atropine to further depress the fetal 
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cardiac vagal tone. The atropine effect on the maternal vagal tone would 
not be as evident because the tone had already been eliminated to a large 
extent by the pentobarbital. There are two other factors one must con-
sider when interpreting the atropine data. 1) The atropine was first 
administered to the mother on a per weight basis; this included litter 
weight. Then the atropine was administered directly to the fetus on a 
per weight basis. It is known that atropine crosses the placenta (Hellman 
and Fellisti, 1967). So that in actuality the fetus was getting in excess 
of the calculated 1 mg/kg dose. 2) Some rodents are known to possess the 
enzyme atropinesterase which degrades belladonna alkaloids (Goodman and 
Gilman, 1975). Although no evidence regarding which species possess this 
enzyme could be located in the literature, perhaps the guinea pig possesses 
the enzyme. In the rabbit, atropinesterase is not present until post-
partum (Sawin and Glick, 1943)·. Therefore if atropinestetase is only 
present in the adult guinea pig, atropine would have a longer half-life 
in the fetus than in the adult. While bearing in mind the effects of 
pentobarbital on vagal tone, the relative concentrations of pentobarbital 
and atropine in the mother and fetus, and the possible presence of atro-
pinesterase; one can see how in these experiments atropine could have 
affected fetal cardiovascular parameters without altering those of the 
adult. As to why basal heart rate but not basal blood pressure in the 
·, 
fetus was affected by atropine's presence, perhaps the compliance of the 
fetal vascular.,beds masked any changes in peripheral sympathetic tone. 
The presence of atropine in the preparation would be expected to 
enhance the blood pressure and heart rate changes produced by norepineph-
rine . This enhancement normally results from the elimination of the 
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baroreceptor reflex. However, no enhancement was seen in my experiments 
either under pentobarbital or methoxyflurane anesthesia. This lack of 
atropine enhancement may be the result of three factors. It is well-
known that, in order to block neural effects with an antagonist, higher 
concentrations than those necessary to block an exogenous compounds 
actions are required. Although the effects of the test dose of acetyl-
choline were blocked by 1 mg/kg of atropine, perhaps this was not a high 
enough concentration to prevent intrinsic inhibitory vagal influence on 
the heart. Secondly, one must consider that a significant amount of 
time elapsed between atropine administration and the norepinephrine 
injections. Therefore if atropinesterase is present in the guinea pig, 
a significant amount of atropine degradation would have occurred, thus 
making the atropine less effective in eliminating vagal influence on the 
heart. Finally, one cannot discount the possibility of anesthetic depres-
sion of cardiovascular reflexes before the administration of atropine. 
This is an especially strong possibility in the experiments in which 
pentobarbital was used. 
The fact that the placental weight was not taken into consideration 
when calculating the drug doses may at first appear to be a possible 
explanation for the decreased fetal sensitivity to the biogenic amines. 
The placental mass is approximately 9-10 percent of the fetal mass 
(Eckstein'et al., 1955). A 10 percent change in doses would not be 
expected to alter the dose response curve enough to account for the large 
difference in the maternal and fetal responsiveness to the drugs tested. 
Although no quantitative analysis was performed on the duration of 
action of the various drugs tested in vivo, there did not appear to be 
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any distinctive difference between the mother and the fetus in this 
aspect. 
The fetal cardiovascular changes seen during the administration of 
the vasoconstrictor drugs to the mother should not be overlooked. The 
possibility of the drugs having crossed the placenta and affecting the 
fetus is excluded by the facts: 1) when comparable doses were given 
directly to the fetus, different fetal responses were obtained than when 
the drug was given to the mother; and 2) studies using H
3
-norepinephrine 
administered to the mother have shown that yery little crosses the placenta 
(Mirkin and Singh, 1972). The most probable explanation for the fetal 
response to maternal norepinephrine administration is that it is the 
result of fetal asphyxia. This asphyxia could come about in two ways. 
The first of which was noticed in experiments using the guinea pig 
(Dornhorst and. Young, 1952). High doses of norepinephrine given to the 
mother resulted in fetal bradycardia and hypotension. These fetal changes 
seemed to be correlated with the placenta becoming cyanotic. This cyanosis 
presumably resulted from the severe peripheral vasoconstriction by norepi-
nephrine, thus decreasing maternal blood flow to the placenta. The 
second possible way to bring about fetal asphyxia depends on whether 
sluice flow exists in the guinea pig placenta (Power and Longo, 1973). 
If sluice flow exists and the blood pressure in the maternal placental 
sinuses is elevated to exceed that of the fetal villi, the villi will 
collapse from the excessive surrounding external pressure, preventing 
proper perfusion of the fetal side of the placenta. This villi collapse 
would have a twofold effect on the fetus: 1) asphyxia and 2) hyperten-
sion, in excess of the pressure in the maternal sinuses, as a result of 
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damming up of the blood on the fetal side of the placenta. 
The fetal responses to asphyxia are variable and depend on the method 
in which asphyxia is induced (Chernoff and Grabowski, 1971; Bauer, 1938; 
Martin and Young, 1960; Gaxiano and Freeman, 1977; James, 1976). The 
fetus may respond with tachycardia and hypertension, as appeared with 
the maternal administration of the lower dose of phenylephrine. However, 
if severe asphyxia occurs, depression of the fetal cardiovascular system 
results and hypotension with bradycardia occurs (Adamsons et al., 1971). 
The transient plateau in the rise of fetal blood pressure in response 
to norepinephrine administration was too consistent to be an injection 
artifact. The initial rise may be the positive inotropic and chronotropic 
effect of norepinephrine on the fetal heart and vasoconstriction of the 
systemic vasculature. The second rise would be the result of norepineph-
rine's effect on the placental vasculature, causing vasoconstriction 
(Panigel, 1962; Euler, 1938). 
The fetal cardiac arrhythmias and arrests which occurred during iso-
proterenol administration may indicate that additional caution should be 
taken during the use of gaseous anesthetics in obstetrics. It is known 
that methoxyflurane sensitizes the adult myocardium to catecholamines 
(Goodman and Gilman, 1975). In my experiments, this sensitization seemed 
to be greater for the fetus than the mother. This is not totally unex-
pe.cted if one considers the differences in conductive systems and metab-
olism demonstrated between the fetal and adult myocardium (Shepard et al., 
1969; Su and Friedman, 1973; Coltart et al., 1971). Although fetal beta
1 
cardiac receptors are present and active, the fetal myocardium metabol-
ically functions differently than the adult myocardium. This aspect of 
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increased frequency of cardiac arrhythmia and arrest in the fetus, in 
response to isoproterenol administration during methoxyflurane anesthesia, 
r~quires further experimentation before definitive statements can be 
made. 
The differences in fetal myocardial metabolism in combination with 
the high level of metabolic activity of cardiac tissue may partially 
explain the deterioration of the fetal atria during my _!!! vitro experi-
ments. And because of this, I was not able to characterize the cardiac 
beta-adrenergic receptors. From the work of others (Wyse et al., 1976; 
Martin et al., 1973; Park et al., 1976) and the characterization of the 
alpha-adrenergic receptors of the guinea pig aorta in my experiments, I 
feel confident in stating that future work will probably indicate a 
similarity between the fetal and maternal beta1-adrenergic receptor 
affinity. 
The fact that isoproterenol caused an increase in blood pressure in 
some adults and a transient decrease in others was presented to illustrate 
the inconsistency of the response to this drug. No explanation for these 
varied responses will be attempted. 
The _!!! vitro experiments using the thoracic aorta showed that the 
alpha-adrenergic receptors of the mother and fetus have the same affinity 
in the guinea pig, as judged by the pA
2 
and ED
50 
values. Therefore, the 
difference in sensitivity to'vasopressors seen between mother and fetus 
is not likely based on a difference of the affinity of the alpha-adrenergic 
receptor to alpha agonists. However, differences between maternal and 
fetal isometric contractions in response to norepinephrine did occur _!!! 
vitro, indicating that there is a difference at the cellular level. The 
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fetal vessels contracted in steps similar to the contractions described 
in.!!!, vitro studies of the ductus arterious (Fay, 1971). However, for 
my experiments, segments were taken from the distal portion of the fetal 
thoracic aorta to avoid the complications presented by the special char-
acteristics of th.e ductus arterious smooth muscle (Cassels, 1973). Per-
haps the smooth muscle of the fetal vasculature is phasic as opposed to 
the tonic type .which is found in the aorta of adult animals (Wolf and 
Werthessen, 1975). Histological studies in addition to electrical 
recordings during contraction would be required to answer this question. 
The slowness of fetal contractions could be the result of decreased intra-
# cellular stores of Ca . Therefore, contraction would be dependent on 
the influx of extracellular ca*. In smooth muscle, it has been suggested 
# 
that mitochondria may act as a sequestering organelle for Ca ions (Wolf 
and Wethessen, 1975). If this is the case and if fetal vessels depend 
primarily on anaerobic glycolysis for energy as does the fetal heart (Su 
and Friedman, 1973; Shepart et al., 1969), the number of mitochondria may 
be decreased compared to that of an adult. If so, the intracellula; Ca++ 
pool would be less in the fetus than the adult. This may give rise to a 
slower, weaker contraction of the fetal vessels in comparison to the 
adult vessels. The large amount of spontaneity in the fetal vessels in 
vitro may have been the result of high oxygen tensions, which are unusual 
for the fetal vessels. Increased oxygen tension is known to cause con-
traction of the smooth muscle of the ductus arterious (Fay, 1971). Per-
haps this oxygen sensitivity also applies to the smooth muscle of the 
fetal thoracic aorta. 
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The alpha-adrenergic receptors of the maternal and fetal guinea 
pig are similar. However, many events must occur following receptor 
activation before muscle contraction takes place (Wolf and Werthessen, 
1975). The possibility that differences between mother and fetus 
exist in the chain of events leading to muscle contraction appears 
strong. 
Studies such as the ones performed in this project have established 
a difference between maternal and fetal sensitivity to vasoactive com-
pounds. However, the cause of this difference still remains to be eluci-
dated. To answer this question of sensitivity difference, many more 
studies, both in vivo and.!.!! vitro, with a strong biochemical basis must 
be performed. Possible in vitro experiments that could be conducted in 
the future to help answer some of the questions formed as a result of 
this study would be: isolated tissue experiments carried out at various 
oxygen tensions to examine the effects of vascular reactivity; the effect 
of inhibition of prostaglandin synthesis on vascular reactivity.; electro-
physiological studies; and Ca++ fluxes .in fetal smooth muscle using com-
pounds such as verapamil, which selectively block spike discha.rges and 
phasic contractions of smooth muscle (Wolf and Werthessen, 1975). Histo-
logical studies of the fetal vascular smooth muscle would also prove 
useful. 
Further in vivo studies could be conducted making use of both spe-
cific agonists and antagonists. To determine the presence of baroreceptor 
activity in the fetus, vagotomies could be performed. The use of micro-
pheres or possibly even flow probes for the measurement of blood flow 
alterations as a result of drug administration in the guinea pig would 
94 
also prove useful. 
This project has shown that, with the proper amount of dexterity 
and basic surgical equipment, fetal guinea pigs can be used to conduct 
acute cardiovascular experiments. The researcher is somewhat limited 
in the type of experiments that can be performed because of the size of 
the animal. However, the preparation has some definite advantages, 
regarding acute preparations, in comparison to sheep. The guinea pig 
is an inexpensive and readily available laboratory animal, so that large 
numbers of experiments can be performed in a short period of time, in 
comparison to sheep experiments. Because of the similarity of the guinea 
pig placenta to that of humans, it would serve as a very good model for 
fetal pharmacokinetic studies. 
Acute preparations have certain disadvantages when studying the 
cardiovascular function, but they are still valuable for the initial 
testing of hypotheses without the expenditure of significant sums of 
money. In addition, the large n values that one can attain with this 
preparation should prove valuable. Dornhorst and Young (1952) and Rosen 
(1976) appear to.be the only investigators to have made use of the guinea 
pig as a model for fetal physiological and pharmacological experiments: 
With this. project, I have shown that more quantitative studies than those 
done in the past are possible, and the techniques developed here have the 
potential to help elucidate the function of the fetal cardiovascular 
system. 
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SUMMARY 
In this project, the techniques were developed for the acute study 
of pharmacodynamic drugs in the near term fetal guinea pig. The technique 
was then used to study the effects on maternal and fetal heart rate and 
blood pressure of the following biogenic amines: norepinephrine, acetyl, 
choline, phenylephrine, and isoproterenol. In addition to these drugs, 
the effects of atropine on cardiovascular responses to norepinephrine 
were examined. 
Upon completion of the in.vivo studies, isolated tissue studies ---
were conducted in order to characterize the cardiovascular adrenergic 
receptors of the maternal and fetal guinea pig. 
The combination of these studies lead to the formulation of the 
following conclusions: 
1) Use of the guinea pig as a model for conducting acute ,!.!! vivo 
fetal cardiovascular experiments is possible. 
2) A ·difference in magnitude of response to biogenic amines with 
respect to blood pressure and heart rate changes exists 
between mother and fetus. 
3) The affinity of the alpha-adrenergic receptors for phentolamine 
in.maternal and fetal blood vessels is similar. 
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APPENDIX A 
Composition of modified Krebs-Henseliet solution: 
grams/liter 
NaCl 6.74 
KCl 0.35 
CaC1
2 2H20 0.20 
Mgso
4 
7H
2
o 0.14 
KH
2
Po
4 0.16 
Na (EDTA) 0.01 
NaHC0
3 1.86 
Glucose (dextrose) 1.42 
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APPENDIX B
1 
An examination of the data clearly indicated that the relationship 
between dosage and percentage change of blood pressure and heart rate is 
nonlinear. Since a linear relationship was desired, a transformation 
was needed. Lacking a theoretical reason to prefer one particular trans-
formation, four different power transformations were tried: log10 (dose), 
dose, '!.Jaose, and 1~dose. Although it was previously thought that 
log
10
(dose) would give a linear relationship, it proved to be inadequate 
for most of the drugs. For instance, with phenylephrine the square root 
transformation reduced the residual sum of squares by 43% from the fit 
obtained by log
10
(dose) for the fetal percent change in blood pressure. 
For norepinephrine under pentobarbital anesthesia, norepinephrine under 
methoxyflurane anesthesia, and phenylephrine under methoxyflurane anes-
thesia, the same transformation was used for both percentage change in 
blood pressure and percentage change in heart rate. For acetylcholine 
under methoxyflurane anesthesia, log10 (dose) worked very well for.per-
centage change blood pressure and square root dose worked very well for 
percentage change in heart rate. Phenylephrine was particularly inter-
esting for percentage change in blood pressure. For the fetuses, square 
root dose was much better than log10 (dose) (20-43% reduction in residual 
sum of squares). But for the mothers, any of the transformations were 
much better than square root dose (30-35% reduction in the residual .sum 
of squares). In order to show that indeed mother and fetus react 
1 . 
Michael D. Hale, Statistics Department, Iowa State University, Ames. 
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differently, a square root transformation was applied to both.l 
Each drug was analyzed separately. After standardizing to a mean 
of zero, a regresssion line was fit to each mother, fetus, and mother-
fetus pair. The residual sum of squares for mother:, RSSM:, and fetus:, 
RSSF:, were then subtracted from the residual sum of squares for mother-
fetus pair:, RSSP:. 
Then the F statistic was: 
n 
E (RSSP: - RSSM: + RSSF:)/n 
i=l 
n 
E (RSSM: + RSSF:)/(T - 4) 
i=l 
with n and T-2n degrees of freedom. Where n is the number of pairs and 
T is the total number of observations for both fetuses and mothers. The 
statistic was used to test whether the rate of response was the same for 
mother and fetus. Similarly, a regression line was fit for each fetus 
and one common regression line fit to all fetuses. Then, 
n 
(RSS common - I: RSSF: )/ (n - 1) 
i=l F = ~~~~~~--"'--=-~~~~~~ 
n 
I: RSSF:/Tf " 2n 
i=l etus 
was formed to test for a common rate of response for fetuses, likewise for 
mothers. 
1 
To prove differences statistically, one assumes a common model. 
~f dat~ show the model to be untenable, then one may assert that there 
is a difference at the level of probability at which the model was 
found unacceptable. 
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To obtain confidence bands and predicted response, a common regres-
sion line was fit to the understandardized data for the fetuses and for 
the mothers. 
